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INTRODUCTION 
Since the middle of the sixties the Division of 
Endocrinology of the Department of Medicine of the Nijmegen 
University Hospital has paid attention to aspects of the 
activity of the renin - angiotensin system and to the pro-
duction of mineralocorticoids in hypertensive syndromes, 
in order to detect endocrine causes of hypertension. 
The dispute on the significance of the renin state of 
the hypertensive patient has become increasingly lively in 
recent years. Extreme points of view have been taken by 
Laragh and coworkers in New York City, who claim an almost 
prophetic role of the activity of the renin - angiotensin 
system in the natural course of the hypertensive process, 
and by the Glasgow group, headed by Lever, who look at the 
renin activity in the peripheral blood as a remote marker 
of adjustments of the kidneys to the circulatory derange-
ments in hypertension. Neither of these extreme views on the 
significance of the activity of the renin-angiotensin system 
seem to account for a number of phenomena observed untili 
the present in this as well as in other laboratories. 
In 1969 Driessen of our group (doctoral thesis, 
Nijmegen), paid attention to the blunted response of the 
renin - angiotensin system in benign essential hypertension 
to stimuli such as sodium restriction and upright posture. 
In those days renin activity was measured by the well known 
Boucher's bioassay. Today, renin activity is assessed by 
radioimmunoassay of generated angiotensin I. Because of a 
still not definitively closed discussion about the corres-
pondence between the results of the bioassay and the radio-
immunoassay a studv was made, which is reported in Chapter I, 
dealing with the comparison of both methods. This study 
will be published in Clinica Chimica Acta (in press). 
In Chapters II and III attention is paid to methods to 
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detect 'low renin' and 'normal renin' hypertensive patients 
on an out-patient base in a meaningful way. In recent 
literature a number of differing methods have been used to 
characterize the renin state of normotensive and hyperten-
sive individuals. Part of the conflicting data and concepts 
based on them in the renin field might be explained by 
important differences in the methodology of the detection 
of the renin state. Part of this study was published in 
Clinical Science and Molecular Medicine, 1975, 48, 91 - 96. 
In Chapter V a study is presented aiming to relate the 
renin state of hypertensive patients to the effect of 
differing modes of drug treatment. This study is part of a 
collaborative effort of the Division of Endocrinology and 
the Out-patient Division of the Department of Internal 
Medicine. In two groups of patients, one composed of normo-
reninemics, the other of hyporeninemics, effects of long-
term treatment with the saluretic drug chlorthalidone, with 
the anti-aldosterone drug spironolactone and with the 
ß-blocker propranolol, a number of variables have been, and 
will be studied. Chapter V discloses results of the study 
in a representative sample of normoreninemic hypertensive 
patients. The effects of these varying drug schedules on 
the blood pressure were of prime importance. Because of the 
limitations of casual auscultatory blood pressure measure-
ment in this type of studv automated blood pressure 
recording was practized instead. In Chapter IV a comparative 
study of blood pressure recording by classical manometry 
and by the automated device used has been reported. 
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Chapter I 
THE RELIABILITY OF THE MEASUREMENT OF PLASMA RENIN 
ACTIVITY BY RADIOIMMUNOASSAY. 
J.I.M. Drayer 
Th.J. Benraad 
Department of Medicine 
Division of Endocrinology 
University of Nijmegen 
Nijmegen 
The Netherlands 
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SUMMARY 
A radioimmunoassay of angiotensin I has been applied 
to the measurement of plasma renin activity. Angiotensin I 
was generated in plasma samples by 3 h incubation at 37° 
and pH 5.6 after addition of EDTA and Dowex. The generated 
amount of angiotensin I was measured by radioimmunoassay 
in the eluate of the Dowex column. With this method a 
negligible amount of angiotensin I was measured after incu­
bation at 4° С (0.8 ng/ml per 3 h). Eluate of blank plasma 
had no measurable effect on the standard curve. The mean 
recovery of angiotensin I was 87 %. The limit of detection 
of the assay was 0.5 ng/ml per 3 h. The results obtained 
using different antisera were equal. A marked variation was 
found in immunological properties of the different standard 
preparations of angiotensin I tested. The mean value of 
angiotensin I generation per Goldblatt Unit (G.U.) renin was 
3.9 . 101* ng/h. In normotensive control subjects, the plasma 
renin concentration, while on unrestricted diet and after 
3 h ambulation, was on'average 0.39 . 10 "· G.U./ml, range 
0.12 . Ю-1* - 0.91 . Ю -". 
With the use of the same plasma extracts for radio­
immunoassay and bioassav, a perfect correlation was found 
between the plasma renin activities measured with both 
assays. The differences found between the results of both 
assays could be fully explained by the different biological 
activities of the standards used (Angiotensin I, Schwarz 
Mann, and Angiotensin II, Ciba-Geigy). 
With a direct radioimmunoassay, angiotensin I was 
generated in plasma by 3 h incubation at 37° С and pH 5.6 
after addition of phenylmethanesulfonyl fluoride, 8-hydroxy-
quinoline and 2.3-dimercaptopropanol (dimercaprol). The 
generated amount of angiotensin I was measured by the above 
mentioned radioimmunoassay. A fair correlation was found 
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between the generated amounts of angiotensin I measured in 
the Dowex eluate and those found in the incubated plasma. 
Especially in the lowest range, lower values were obtained 
by the latter assay. However, the generated amounts of 
angiotensin I measured in non-incubated plasma samples (3 h 
at 4° C) was on average 6.4 ng/ml per 3 h and accounted for 
7 - 48 % of the amounts found after incubation at 37° C. 
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INTRODUCTION 
Various laboratories discontinued the use of the bio-
assay method for the measurement of plasma renin activity 
(PRA) and developed a radioimmunoassay system. There are 
obvious reasons for such developments because the bioassay 
technique, although reliable, is a relatively insensitive, 
difficult and laborious procedure. Unfortunately, the 
results obtained by radioimmunoassay have been described 
to deviate widely, some investigators (1, 2) reporting 
lower, most however (3 - 7), higher values than obtained 
by bioassay. The variability in incubation conditions for 
generating angiotensin and the use of different angiotensin 
standards have been reported to be the explanation for 
these differences (6, 8). However, the generation of 
material cross-reacting in the immunoassay, the presence of 
biologically inactive though immunologically active frag-
ments in the immunoassay are still considered to be more or 
less responsible for the discrepancies found between both 
assays (4, 7 - 10) . 
In this report the results of measurement of plasma 
renin activity by bioassay were compared with those obtained 
by radioimmunoassay. Angiotensin I was generated under iden-
tical conditions in both assays using Dowex extraction. The 
radioimmunoassay after purification was compared with a 
simplified radioimmunoassay procedure without extraction of 
the incubation product. Sensitivity and accuracy of the 
radioimmunoassay were analyzed and attention was paid to 
calibration with the use of the international standard of 
renin. 
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REAGENTS 
Albumin, bovine 96 - 99 % (Sigma). 
Ammonium acetate (Merck), 0.2 N solution in sterile 
distilled water, acidified to pH 6 with glacial acetic 
acid. 
Ammonium hydroxide (Merck), 0.2 N solution in sterile 
distilled water. 
Angiotensin I standards: 
Asp1 - lie5 Angiotensin I (Schwarz Mann, Orangeburg, 
New York, USA), batch November 1972 and May 1974. 
Asp1 - lie5 synthetic Angiotensin I 71/328 (Medical 
Research Council, Divison of Biological Standards, National 
Institute for Medical Research, Hampstead Laboratories, 
Holly Hill, London, England). 
Human synthetic angiotensin"I (Beekman Instruments 
Inc., Geneva, Switzerland). 
lie5 angiotensin I (Sorin,Inco, Amerongen, The 
Netherlands). All standards diluted with Tris buffer and 
stored in 50 yl aliquots,containing 2500 ng,at - 20° C. This 
solution keeps for at least 6 months. 
Angiotensin II standard: 
Asp1 -β amide-Val5-Angiotensin II (Hypertensin, 
Ciba-Geigy). 
Antiserum A and B, raised in rabbits against angiotensin 
I in 1972 and 1973 respectively (generously supplied by 
Dr. H.J.G. Hollemans, Department of Endocrinology, Wilhelmina 
Gasthuis, University of Amsterdam, The Netherlands). The 
antisera were stored, diluted 1 : 1000 in Tris buffer, in 
0.2 ml samples at - 20° C. 
Bovine serum albumin, BSA (Behringwerke AG), 5 % solution 
in sterile distilled water. 
Butan-1-ol (Merck). 
DASP, sheep anti-rabbit γ-globulin immunosorbent, vials 
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of 5.5 ml (Organon, Oss, The Netherlands), each vial diluted 
with Tris buffer to 25 ml. 
Dibenzyline, Dibenamine (phenoxybenzamine) (Smith, 
Kline and French Labs Ltd), 0.05 % solution in sterile dis­
tilled water. 
Diethylamine (Merck), fraction-distilled twice at 5.5° 
C, 0.1 N solution in sterile distilled water, 
2.3 Dimercapto - 1 - propanol (Fluka AG). 
Disodiumhydrogen phosphate . 12 H 20. (Merck) pure 
crystalline. 
Disodium EDTA, Titriplex III (Merck), 10 % solution in 
sterile distilled water. 
Dowex 50W-x2, 100 - 200 mesh (Baker's Analyzed Reagent). 
After washing the Dowex with distilled water (2000 ml per 
500 g) the Dowex was poured into a column with a glasswool 
filter. Subsequently 2 χ 1000 ml 4 N NaOH was poured onto 
the Dowex. After washing with 2 χ 500 ml distilled water the 
column was washed first with 1000 ml 2 N HCl and distilled 
water to pH 7.0 and secondly with 4000 ml 0.2 N ammonium 
acetate to pH 6.0. The Dowex (NH4 ) prepared in this way was 
stored at 4° С until needed. 
Ethanol 100 % (Merck), 80 % solution in sterile 
distilled water. 
Ether anaestheticus (Kon. Ned. Gist- en Spiritusfabrie-
ken) . 
Glacial acetic acid 99 % (Merck), 10 % solution in 
sterile distilled water. 
HCl (Merck), 0.01, 1, 2 and 4 N solutions in sterile 
distilled water. 
8-Hydroxyquinoline sulfate (Fluka AG). 
(*25I)-Angiotensin I, CEA - Sorin (Ire, Moll, Belgium) 
stored at - 20° C. 
Lysozume, (Boehringer). 
Merthiolate, Thiomersal (BDH). 
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NaCl (Merck). 
NaOH (Merck), 4 N solution in sterile distilled water. 
Neomycin sulfate (Lundbeck). 
Pentolinium tartrate 0.5 %, Ansolysen (May and Baker 
Ltd) . 
Phenylmercury acetate (BDH). 
Phenylmethanesulfonyl fluoride, PMSF (Merck). 
Phosphate buffer, pH 7.6, containing per 1000 ml sterile 
distilled water, 5.74 g disodiumhydrogen phosphate . 12 H20, 
0.42 g potassiumhydrogen phosphate and 0.1 g merthiolate. 
Potassiumhydrogen phosphate (Merck). 
PMSF solution, containing per 10 ml sterile distilled 
water, 1 g neomycin sulfate, 500 mg PMSF, 500 mg 8-hydroxy-
quinoline sulfate and 0.32 ymol dimercaprol. 
Standard renin, 0.1 Goldblatt Unit per ampoule (M.R.C., 
Hampstead Laboratories, Holly Hill, London, England). The 
content of one ampoule was dissolved in 2 ml Tris buffer and 
10 or 20 ul of this solution, containing 1/2000 and 1/1000 
G.U. respectively, was added to plasma samples. 
Sterile distilled water. 
Thymol blue indicator (BDH). 
Tris buffer, containing per 1000 ml sterile distilled 
water: 12.1 g Tris, 3.0 g BSA, 2.0 g neomycin sulfate, 
0.034 g phenylmercury acetate, 3.0 g lysozyme. This solution 
was acidified to pH 7.5 with glacial acetic acid. 
Trizma base (Sigma). 
Urethane ethylcarbamate (BDH), 50 % solution in sterile 
distilled water. 
METHODS 
Blood was collected in ice-cooled containers. Disodium 
EDTA, 0.1 ml of 10 % solution per 10 ml blood, was used as 
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an anticoagulant and as a blocker of the converting enzyme 
and the angiotensinase activity. The blood was centrifuged 
for 15 minutes, 3000 rpm at 4° С and the plasma was stored 
at - 20° С until assay. 
Bioassay of the plasma renin activity. 
Angiotensin I 2eneration_and_purif¿cation. 
Plasma was thawed avoiding a rise in temperature 
above 4° C. To 10 ml plasma 4 ml of the Dowex suspension 
was added and the mixture was acidified to pH 5.6 with 
1 N HCl. Incubation was carried out for 3 hours at 37° С 
while gently shaking. After incubation the mixture was 
poured into a column containing 1 ml Dowex suspension. The 
column was washed with 30 ml 0.2 N ammonium acetate, 30 ml 
10 % acetic acid and 30 ml distilled water subsequently. 
The angiotensin I, generated during incubation, was eluted 
from the column with 15 ml 0.1 N diethylamine and 20 ml 
0.2 N ammonium hydroxide. To the eluate, acidified with 
0.25 ml glacial acetic acid, 10 ml 80 % ethanol was added. 
The solution was concentrated to 2 ml under reduced 
pressure by flask-evaporation and subsequently heated in a 
boiling water bath for 15 minutes. After cooling to room 
temperature the solution, was acidified to pH 5.0 with 
4 N HCl, using thymol blue as an indicator, and saturated 
with sodium chloride. Extraction of the angiotensin was 
performed with 25, 10 and 8 ml butanol and the angiotensin I 
was reextracted with 3 χ 15 and 2 χ 5 ml 0.01 N HCl. After 
addition of 4 ml 80 % ethanol, the aqueous alcoholic 
solution was, under reduced pressure, flask-evaporated to 
dryness. The residue was dissolved in 2 ml 5 % bovine serum 
albumin just before bioassay. 
In some experiments the angiotensin I was assayed by 
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radioimmunoassay of the final bioassay extract. In these 
cases the residue was dissolved in Tris buffer. 
Angiotensin I bioassay^ 
The angiotensin I bioassay was performed in two 
nephrectomized male Wistar rats. The nephrectomy was carried 
out under ether anaesthesia about 18 hours before bioassay. 
Depending on the weight of the rats (190 - 270 g) an intra-
abdominal injection of 0.39 - 0.46 ml 50 % urethane was 
given as an anaesthetic. A tracheotomy was performed to 
prevent airway obstruction. Two cannulae were placed in the 
right jugular vein, one for the administration of the stan-
dard angiotensin II and one for the injection of the final 
bioassay extract. The blood pressure was measured by a 
Statham pressure transducer connected with an indwelling 
catheter in the left carotid artery. A weight related dose 
of 0.5 % pentolinium tartrate (0.4 - 1.2 ml) and 0.05 % 
dibenzyline (0.80 - 1.90 ml) was given subcutaneously, re-
sulting in a final blood pressure of 40 - 80 mmHg. After 
about one hour the pressor effect of a volume of the final 
extract BSA solution was compared to the pressor effect of 
known amounts of the angiotensin II standard BSA 5 % 
solution in both rats. The final extract of an unknown 
plasma was assayed twice in each rat, using single and 
double doses of the extract. 
The bioassay of the PRA described here is essentially 
the procedure of Boucher et al. (11) modified in this labo-
ratory (12). The coefficient of variation, determined by 
analysing plasma pools repeatedly, was 9, 10 and 12 % for 
pools containing 5, 12 and 32 ng angiotensin/ml per 3 h 
respectively. The recovery of the bioassav was 8 9 + 1 1 %. 
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Radioimmunoassay of the plasma renin activity. 
Procedure A. 
Angiotensin I_ 2eBe£a t ion_and_pur i f ica t ion . 
The volume of the plasma analyzed was 2.5 ml. The 
incubation, washing and elution procedures were carried 
out as described for the bioassay, using the following 
volumes of reagents. One ml of fche Dowex suspension was 
added to the plasma. The column, containing 1 ml Dowex 
suspension, was washed with 30 ml 0.2 N ammonium acetate, 
30 ml 10 % acetic acid and 30 ml distilled water. The 
angiotensin I was eluted with 10 ml 0.1 N diethylamine and 
15 ml 0.2 N ammonium hydroxide. The eluate was acidified 
with 0.2 ml glacial acetic acid. According to the amount 
of angiotensin I expected to be present in the eluate, 
the eluate was used either undiluted or after dilution 
with Tris buffer or after concentration by evaporation of 
an appriopriate amount of solvent on a water-bath at 60° C. 
Angiotensin 1^  radioimmunoassay_¡_ 
The incubation mixture for the radioimmunoassay was 
prepared as follows: 
50 μΐ antiserum (final dilution of antiserum 
A 1 : 240 000 and antiserum В 1 : 1 100 000). 
50 μΐ 125I-labeled angiotensin I (about 3000 cpm, 
containing 1.5 - 8 pg angiotensin I). 
20 μΐ or 40 μΐ of the unknown sample or 
20 μΐ Tris buffer containing standard angiotensin I 
900 μΐ Tris buffer. 
The incubation was performed for 20 hours at 4° C. After 
incubation 0.5 ml DASP-suspension was added to separate the 
antibody-bound and free hormone. The mixture was rotated 
20 
for 2.5 hours at 4° C. After centrifugation the supernatant 
was aspirated and the residue washed twice with 2 ml phos­
phate buffer. After the final centrifugation, the precipitate, 
containing the bound hormone, was counted in a Wallac 
sample counter (GTL 300 - 500) . 
The PRA of the plasma samples was calculated according 
to the formula: χ = a/b . (c . 10) in which χ is the PRA 
(ng/ml per 3 h), ais the amount of angiotensin I present in 
the DASP precipitate (pg), h is the amount of Dowex eluate 
added to the radioimmunoassay incubation mixture (μΐ) and с 
is the dilution or concentration factor of the Dowex eluate. 
In the routine assay procedure the antiserum В was used 
with the angiotensin I standard from Schwarz Mann. 
Procedure B. 
Angiotensin 1^  £ener a tion_and_r ad i^o immunoassay. 
0.1 ml PMSF solution was added to 2.5 ml plasma. The 
plasma was adjusted to pH 5.6 with 1 N HCl. Two 1 ml 
samples of the plasma were incubated for 3 hours at 4 and 
37° C, respectively. To this point the procedure described 
by Freedlender et al. (13) was followed. The angiotensin I 
generated in the incubated samples was radioimmunoassayed 
as described for Procedure A. 
Standard statistical tests were used to detect diffe-
rences between two groups and to calculate correlation 
coefficients. The results are expressed as means + standard 
deviation. 
RESULTS 
Unless stated, the results presented were obtained 
using radioimmunoassay procedure A as described in the 
methods section. 
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Standard curve. 
Routinely, the standard curve of angiotensin I was 
set up in triplicate. Fig. 1 shows the mean and standard de-
viation of triplicates from 6 standard curves obtained on 
different days within a period of two months. The standard 
deviation for antibody alone (B0) was 0.9 % and after addi-
tion of 10, 25,50 and 100 pg angiotensin I this value 
ranged from 0.9 to 1.1 %. After addition of 150 and 250 pg 
angiotensin I the standard deviation was 0.4 %. Only that 
part of the curve between 10 and 200 pg angiotensin I was 
used in practice. 
bound ( % ) , 
I 
60 
50 
40 
30-
20-
10-
~25 75 125 175 225 275 ( pg /tube) 
angiotensin I 
Fig. 1. MEAN AND STANDARD DEVIATION OF 6 STANDARD CURVES. 
EACH STANDARD CURVE WAS ASSAYED IN TRIPLICATE WITH THE 
RADIOIMMUNOASSAY PROCEDURE A. 
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Blank. 
Dowex eluates (20 and 40 yl) of plasma samples of bi­
laterally nephrectomized patients added to the entire range 
of the standard curve did not alter the binding of the 
labelled hormone to the antibody. Therefore the blank of the 
method appeared to be zero. 
Precision and sensitivity of the radioimmunoassay. 
The precision obtained in the assay of plasma samples 
was studied by carrying out duplicate assays of plasma 
eluates containing different ranges of angiotensin I concen­
trations (Table 1). 
Table 1. PRECISION AND SENSITIVITY OF DUPLICATE ASSAYS OF 
PRA IN PLASMA SAMPLES MEASURED BY RADIOIMMUNOASSAY 
(PROCEDURE A ) . 
OF PLASMA RLNIN 
ITY VALUES IN THE 
LASMA SAMPLES 
ng/ml.3h 
0 - 5 
3 - 1 0 
10 - JO 
30 - 60 
60 - 90 
NUMBER OF 
DUPLICATES 
π 
21 
14 
32 
28 
21 
COEFFICIENT 
OF 
VARIATION 
% 
14 6 
12.3 
12.4 
5.9 
5.1 
PRECISION 
ng/ml.3h 
0.4 
0.9 
2.5 
2 5 
3.6 
SENSITIVITY 
(p < 0.04 
ng/ml 3h 
0.5 
1.3 
3 6 
3 7 
5 3 
The precision, S, in ng/ml per 3 h was calculated according 
to the formula 
S = тг-М/ Σ (χ. . - χ. τ ) 2 2η Y i = 1 il ι2' 
in which χ., and χ · 2 are the values of the i-th duplicate 
and η is the number of the duplicate pairs. From this 
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precision, the sensitivity of the method in a duplicate 
assay was calculated according to the formula 
sensitivity (ng/ml per 3 h) = t χ S//2 
in which t is the critical value at the 5 % level of the 
Student-t test for η degrees of freedom. The sensitivity 
is the smallest duplicate mean value differing signifi­
cantly (p < 0.05) from zero. 
From the results presented in table 1 the sensitivity 
appeared to be 0.5 ng/ml per 3 h. 
The limit of detection has also been predicted by 
analysing the variance of the blank of the standard curve, 
assuming equality of blank and sample variances, and using 
a one-sided t-test at ρ < 0.05 (14). In this way the pre­
dicted limit of detection was calculated to be 5 pg per 
tube. Assuming this amount to be present in 40 μΐ of the 
concentrated (5 times) eluate, this results in a sensitivity 
of 0.25 ng/ml per 3 h. Obviously the actual sensitivity is 
lower than this theoretical value. 
Between assay replicate variation. 
Three pooled plasma samples with different PRA values 
were analyzed repeatedly on separate days. From the results 
presented in Table 2 it appears that the coefficient of 
variation was about 13 % and did not differ substantially 
between the different plasma pools. 
Parallelism. 
Parallelism of the immunological response of generated 
angiotensin I and standard angiotensin I was evaluated by 
comparing the angiotensin I concentrations (pg/yl) measured 
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Table 2. BETWEEN ASSAY REPLICATE VARIATION OF THE RADIO­
IMMUNOASSAY (PROCEDURE A). 
PLASMA 
POOL 
I 
II 
III 
NUMBER OF 
REPLICATE 
ASSAYS 
15 
15 
13 
PLASMA RENIN 
ACTIVITY 
ng/ml.3h 
mean + SD 
12.2 + 1.6 
29.9 + 4.5 
52.5 + 6.0 
COEFFICIENT OF 
VARIATION 
% 
12.9 
15.0 
11.4 
in a 20 μΐ aliquot and in a 4 0 μΐ aliquot of the Dowex 
eluate of different plasma samples. The differences were 
calculated for a lower (0.5 - 2.5) and a higher (2.5 - 10) 
range of angiotensin I concentrations. The mean difference 
for the lower range was 0.04 + 0.18 (n = 32, n.s.) and for 
the higher range 0.06 + 0.19 (n = 41, n.s.). 
Recovery. 
The accuracv of the method was evaluated by adding 
known amounts of angiotensin I, in a range from 1 to 75 ng, 
to different plasma samples. In Table 3 the percentage 
recoveries are presented in relation to the initial amount 
of angiotensin I present in the plasma samples, and in rela­
tion to the amount of angiotensin I added to those samples. 
In general the percentage recovery increases with the amount 
of angiotensin I added. There does not seem to be a signi­
ficant correlation between the percentage recovery and the 
initial amount of angiotensin I present. Overall, the 
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recoverv was 8 7 + 1 7 %. A highly significant positive 
correlation was found between the added amount of angio­
tensin I and the recovered amount of angiotensin r = 0.98, 
η = 41, ρ < 0.001). 
Table 3. RECOVERY (%) OF THE RADIOIMMUNOASSAY PROCEDURE A. 
Generation of angiotensin I during incubation. 
Eight plasma samples were incubated for zero to 4 hours 
and the generated amount of angiotensin I was measured 
(Fig. 2). During the first three hours of incubation a 
linear generation slope was found in all plasma samples. 
After 3 hours, a decline in angiotensin I generation was 
observed in 3 plasma samples. Incubation of all plasma 
samples at 4° С for 3 hours resulted in a generation of 
minimal amounts of angiotensin I. A mean of 0.8 ng/ml per 
3 h was measured which did not differ significantly from 
the value before incubation, 0.7 ng/ml per 3 h. 
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PRA 
( ng/ml -incubation time) 
80 
70 
60 
50-
40 
30 
20-
10-
O 1 2 3 4 ( h j 
incubation time 
Fig. 2. GENERATION OF ANGIOTENSIN I, MEASURED BY RADIOIMMU­
NOASSAY (PROCEDURE A). ·, PRA MEASURED AFTER INCUBATION AT 
37° С FOR DIFFERENT PERIODS, °, PRA MEASURED AFTER INCUBATION 
AT 4° С FOR 3 HOURS. 
Differences between angiotensin I standards. 
Standard curves as presented in Fig. 3 were obtained 
when different preparations of the angiotensin I peptide 
were used. It is clear that the preparations vary widely 
as far as their immunological properties are concerned. The 
two batches of the Schwarz Mann preparation and the Beekman 
standard gave identical results. Compared with these curves 
those obtained with the Medical Research Council standard 
and the Sorin preparation differed widely. Angiotensin II, 
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up to a concentration of 1000 pg per tube, did not displace 
tracer to any degree. 
Уво<°'°> 
25 75 125 175 225 275 (pg/tube) 
angiotensin I 
Fig. 3. DIFFERENCES BETWEEN ANGIOTENSIN I STANDARDS. THE 
STANDARD CURVES WERE ASSAYED WITH RADIOIMMUNOASSAY 
PROCEDURE A. 
Use of different antisera. 
The standard curves obtained using two different anti-
sera A and B, are shown in Fig. 4. From the Scatchard plots 
the dissociation constants of 10 . 10 12 and 28 . 10 1 2 
mol/1 were calculated for the respective antisera. Fourteen 
plasma samples were analyzed with the use of these two 
distinct antisera. The results are presented in Table 4. 
The correlation between the two series of results was 
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highly significantly positive (r = 0.998, η = 14, ρ < 0.001) 
• antiserum Α ι 240 00c 
о antiserum Β ι 1100000 
25 75 125 175 225 275 (pg/tube) 
angiotensin I 
Fig. 4. STANDARD CURVES OBTAINED BY RADIOIMMUNOASSAY 
PROCEDURE A, USING TWO DIFFERENT ANTISERA. 
Calibration. 
To compare results obtained by this radioimmunoassay 
(Procedure A) with those obtained by other assays, two 
different plasma samples were incubated in the absence and 
presence of 0.001 and 0.0005 Goldblatt Unit (G.U.) standard 
renin, respectively. The results are presented in Table 5. 
The rate of angiotensin I generation (ng/h) by standard 
renin was almost identical in both plasma samples and 
increased twice by doubling the amount of renin added. The 
generated amount of angiotensin I was in both samples 
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T a b l e 4 . PRA VALUES MEASURED BY RADIOIMMUNOASSAY PROCEDURE 
A USING TWO DIFFERENT ANTISERA. 
ANTISERUM A: FINAL DILUTION 1 : 2 4 0 . 0 0 0 . ANTISERUM B: FINAL 
DILUTION 1 : 1 . 1 0 0 . 0 0 0 . CORRELATION COEFFICIENT r = 0 . 9 9 , 
ρ < 0 . 0 0 1 . 
PLASMA 
SAMPLE 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
PSA (ng 
ANTISERUM A 
α 
4 .4 
7 . 5 
1 1 . 4 
1 6 . 4 
2 6 . J 
3 1 . 4 
3 7 . 7 
4 0 . 9 
4 1 . 3 
41 . 9 
4 2 . 2 
4 3 . 3 
1 3 0 . 6 
m l . 3n) 
ANTISERUM В 
0 
6 . 5 
5 . 0 
1 2 . 7 
1 5 . 5 
2 5 . 3 
3 0 . 0 
3 5 . 8 
3 7 . 5 
3 9 . 8 
4 5 . 6 
4 3 . 1 
4 5 . 0 
1 3 8 . 1 
T a b l e 5 . RATE OF ANGIOTENSIN I GENERATION BY STANDARD RENIN. 
THE GENERATED AMOUNTS OF ANGIOTENSIN I WERE MEASURED BY 
RADIOIMMUNOASSAY PROCEDURE A. 
2 . 5 ml 
5 .0 ml 
2 . 5 n l 
2 . 5 ml 
5 .0 ml 
PLASMA 
SAMPLE * 
1 
i n c u b a t e d 
i n c u b a t e d 
2 
i n c u b a t e d 
i n c u b a t e i 
i n c u b a t e d 
f o r 3 h 
f o r 3 h 
f o r 1.5 h 
f o r 3 h 
f o r 3 h 
STANDARD REÌJIN 
1 /1000 G.U. 1 1 /2000 <3.y. 
ANGIOTENSIN I r . ç /h 
3 9 . 3 
3 4 . 7 
4 0 . 6 
3 8 . 5 
3 9 . 3 
1 4 . 0 
1 8 . 5 
2 1 . 9 
2 2 . 1 
1 9 . 5 
* Rate of angiotensin I generation without standard renin 
plasma 1: 15.3 + 3.9 ng/mJ.h 
plasma 2: 6.7 + 1.5 ng/ml.h 
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independent of the volume of the plasma used which excludes 
substrate deficiency. From the results obtained in the 
experiment in which plasma sample 2 was incubated for 1.5 
and 3 hours it appeared that the rate of angiotensin I 
generation, expressed as ng/h, was equal for both incubation 
times and therefore linear with time. The mean value of 
angiotensin I generation per G.U. was, in terms of the 
Schwarz Mann Standard 3.9 + 0.3 . IO"1 ng angiotensin per 
hour. 
Concentration of plasma renin. 
In 22 normotensive subjects (17 - 55 years) using an 
unrestr Lcted diet the mean PRA measured after 3 hours of 
ambulation was 4.6 + 2.5 ng/ml per 3 h (Schwarz Mann 
Standard). By dividing the PRA by the rate of angiotensin I 
generation by standard renin,the mean plasma renin concen­
tration of these normal individuals was calculated to be 
0.39 . 10-'* G.U. renin/ml plasma (range from 0.12 . 10-1, 
to 0.91 . 10~" G.U./ml). 
Radioimmunoassay versus bioassay of PRA. 
As was described in the methods section, the bioassay 
was performed after extraction of angiotensin I onto Dowex 
suspension and further purification . The final extracts of 
24 plasma samples were both radioimmunoassayed and bio-
assayed. The correlation between the results of the two 
methods was perfect as is shown in Fig. 5A (r = 0.92, 
ρ < 0.001). The radioimmunoassay values were 2.4 + 0.6 times 
higher than those obtained by bioassay. It is emphasized 
that in the radioimmunoassay, angiotensin I from Schwarz 
Mann was used as the home standard and in the bioassay the 
angiotensin II standard from Ciba-Ceigy. Comparing both 
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radioimmuno assay — 
(angio I)PRA(ng/ml -3h) 
100 
во 
6C 
40 
20 
/ • ' 
. ./ 
г - 0 9 2 
p<0001 
rat io Κ»/ · 2 . 4 ! 0 6 
5 10 15 20 25 30 35 40 5 10 15 20 25 30 35 40 
Bioassay(angiolI)PRA (ng/ml.3h) 
Fig. 5. COMPARISON OF THE RADIOIMMUNOASSAY, PROCEDURE A, 
WITH THE BIOASSAY. 
A. PRA MEASURED IN THE FINAL BIOASSAY EXTRACT WITH BOTH 
ASSAYS. 
B. PRA MEASURED IN THE DOWEX ELUATE BY RADIOIMMUNOASSAY AND 
IN THE FINAL EXTRACT BY BIOASSAY. 
standards with respect to their pressor activity in the rat, 
angiotensin II appeared to be 2.5 + 0.1 times more potent 
(5 experiments). Therefore, the above mentioned difference 
between the radioimmunoassay and bioassay values could be 
completely accounted for by this difference in the pressor 
activity of these two standard preparations, the commercially 
available angiotensin I (Schwarz Mann) and the angiotensin 
II preparation (Ciba-Geigy) used. 
From these data it appears that equal results with both 
the radioimmunoassay and the bioassay can be obtained using 
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an identical incubation procedure and standard. However, for 
a routine assay the further purification of the Dowex 
eluate was too laborious and therefore omitted. In a large 
series of 87 plasma samples the PRA with this routine assay 
was compared with the bioassay. The results are presented 
in Fig. 5B. A highly significant positive correlation was 
calculated between both methods (r = 0.95, ρ < 0.001). The 
radioimmunoassay values were 2.9 + 0.9 times higher than 
those determined by bioassay. 
Radioimmunoassay with Dowex extraction (Procedure A) versus 
a direct radioimmunoassay (Procedure B). 
In 27 plasma samples the PRA was measured with both 
assays. As is shown in Fig. 6 a highly significant positive 
correlation between the values was found (r = 0.88, 
ρ < 0.001). However, it should be noticed that, roughly, in 
the lower range of PRA values procedure В gave lower assay 
results than procedure A, whereas, in the higher range of 
PRA values procedure В gave equal or higher results than 
procedure A. The mean ratio between the results of procedure 
A and procedure В was 1.3 + 0.5. Moreover, when in the 
direct assay plasma was incubated for 3 hours at 4° С, a 
definite amount of angiotensin I or angiotensin I-like 
activity was generated (6.4 + 4.2 ng/ml per 3 h) in contrast 
to the negligible amounts which were measured under these 
circumstances by procedure A. This amount has to be subtrac­
ted from the values obtained after the incubation at 37° C, 
and this correction was in fact made for the data presented 
in Fig. 6. A significant positive correlation was found, 
surprisingly, between generated amounts of angiotensin I 
after incubation for 3 hours at 37° С and the amounts of 
angiotensin I or angiotensin I-like activity generated 
after incubation for 3 hours at 4 е С (r = 0.74, ρ < 0.001). 
3.3 
procedure A PRA( ng/ml .3h) 
120 
100-
80 
60-
40 
s/ • 
20 /\? · 
V, , , , , r—, , J 
20 40 60 80 100 120 140 160 180 
procedure В PRA (ng/ml-Зг. ) 
Fig. 6. COMPARISON OF TWO RADIOIMMUNOASSAY METHODS. 
PROCEDURE A: AN ASSAY USING DOWEX EXTRACTION. 
PROCEDURE B: A DIRECT ASSAY IN PLASMA. 
DISCUSSION 
Various authors have pointed out that inherent 
difficulties can be expected when comparing results of 
angiotensin measurements by bioassay and radioimmunoassay. 
It has been reported, as stated in the introduction, that 
biologically inactive fragments might be immunologically 
active, or that immunological cross-reacting substances 
might be present (4.7 - 10). Furthermore, as has been 
emphasized recently by Oparil and Haber (15): 'Variability 
in incubation conditions for generating angiotensin and in 
angiotensin standards has made comparison between bioassay 
and radioimmunoassay of plasma renin activity difficult to 
interpret'. 
In the present report, studying the reliability of the 
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measurement of PRA, experiments were performed in which the 
incubation conditions for generating angiotensin I were 
identical in both the radioimmunoassay and the bioassay. In 
our bioassay, however, Asp1-ß-amide-Val5 Angiotensin II 
(Ciba-Geigy) was used as the standard which, in the bioassay 
era, was generally accepted as an unofficial standard (16). 
In the radioimmunoassay the commercially available Asp1-
Ile5 angiotensin I (Schwarz Mann) was used as the 'home' 
standard. The pressor effect of this angiotensin I standard 
was in our bioassay 0.4 times that of the formerly used 
angiotensin II, which is in agreement with the findings of 
Rössler et al. (5). Corrected for this difference in vaso-
pressor activity, the values of PRA with the two-methods 
were indeed in perfect agreement. This conclusion of our 
study is in agreement with the data Fukuchi et al. (17), 
Waite et al. (7) and Menard and Catt (8), the last authors 
using rat plasma, in contradiction, however, with results 
reported by other authors (1, 4, 5). All authors mentioned 
here used identical incubation conditions and identical 
standards in both assay. 
As appears from this study the immunoreactivity of 
various angiotensin I preparations may vary widely which 
makes comparison of data of different laboratories difficult. 
Haas and Goldblatt (2)femphasizing that estimates of renin 
in termsof 'plasma renin activity' are per se unsuitable 
for comparison studies, recommended the use of an inter-
national standard renin. They recalculated the results of 
a number of published radioimmunoassay procedures using 
endogeneous substrate in which values were reported for 
ambulatory normal subjects on unrestricted diets. In terms 
of Goldblatt Units these values ranged from 0.24 to 
0.73 . Ю-1* G.U./ml plasma (mean: 0.4 . 10~ц G.U./ml 
plasma). Our normal value, determined by radioimmunoassay, 
was on average 0.39 . 10 "* G.U./ml plasma, varying from 
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0.12 . 10~" to 0.91 . Ю - " which fits very well into this 
range. Addition of standard renin to two different plasma 
samples resulted in angiotensin I generation which was 
linear with time, with the amount of renin added, and the 
generated amount was independent of the volume of the plasma 
used, which demonstrates abundance of substrate present. 
The reliability of the radioimmunoassay performed with 
procedure A was further indicated by the observation that 
the use of two antisera of different sources with different 
dissociation constants, gave equal values of PRA in a series 
of 14 plasma samples. Furthermore, incubation of plasma 
samples obtained from bilaterally nephrectomized patients 
did not generate measurable quantities of immunologically 
active substances. The concentrations of angiotensin present, 
whether 20 or 40 yl of the Dowex eluate were radiolmmuno-
assayed, did not differ significantly. 
Several investigators observed a presumably non­
specific blank value in the radioimmunoassay of 'non-incuba­
ted' plasma samples. The presence of this blank necessitates 
correction of the 'incubated' value (10, 18, 19). Oparil et 
al. (20) recently found in plasma samples from anephric 
patients, after incubation at pH 5.5, for 18 hours in the 
presence of enzyme inhibitors, a non-renin-related generation 
of angiotensin I which could make a major contribution to 
total 'renin activity'. Obviously, by the method described 
here, this immuno-reactive material was removed by the 
Dowex extraction. A negligible blank was observed, which is 
in line with reports of others (4, 7, 8, 10). In procedure 
B, in which Dowex extraction was not used, a definite blank 
value was found ranging from 7 to as high as 48 % of the 
'incubated' value. After subtraction of the blank value, 
an overall fair correspondance was observed between the 
values obtained with both radioimmunoassay procedures A and 
B. However, on scrutinizing the data of Fig. 6, especially 
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in the range of the low angiotensin values, method В gave 
lower values than the radioimmunoassay after Dowex extrac­
tion, method A. Because of these considerations a radio­
immunoassay in which Dowex is present as the absorbent is 
used in this laboratory. 
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The editorial board of the journal 'Clinical Science 
and Molecular Medicine' decided the plasma renin activity 
to be expressed in Standard International Units, i.e., 
nmol.3 h '.1 l . To enable the comparison of the renin 
results in this study with those in the other studies of 
the thesis the renin values in this study have to be 
1297 
multiplied bv TñKñ ~ 1-297. The nominator of this factor 
is the molecular weight of human angiotensin I and the 
denominator is used in order to express the values after 
recalculation as ng.ml !.3 h '. 
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SUMMARY 
1. Three renin-stimulating methods for detection of 
low-renin hypertension have been compared. First, renin 
activity was measured in hospital patients after 5 days of 
sodium restriction and 3 h ambulation. Secondly, renin 
activity was measured after frusemide stimulation (0.42 
mmol (140 mg) in 18 h) and 3 h ambulation. Thirdly, renin 
activity was measured after 5 days of chlorthalidone treat-
ment (0.3 mmol (100 mg)/day) and 3 h ambulation. The last 
two tests were done with the subjects as out-patients 
without any dietary regimen. 
2. In eleven normotensive control subjects and twenty 
hypertensive patients the results after frusemide were not 
comparable with those after sodium restriction since the 
frusemide test did not identify the same renin-suppressed 
hypertensive subjects as the sodium-restriction procedure. 
3. After 5 days of chlorthalidone treatment the renin 
values in eleven control subjects as well as in thirty-
eight hypertensive patients were significantly higher than 
after sodium restriction. The values obtained after each 
procedure were closely correlated. 
4. Thus the out-patient chlorthalidone procedure 
identified similar sub-groups of patients as having low- or 
normal-renin hypertension as did the in-patient sodium-
restriction test. 
Key words: low-renin hypertension, sodium restriction, 
frusemide, chlorthalidone. 
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INTRODUCTION 
In fourteen studies, each involving at least fifty 
hypertensive subjects, the percentage of patients with low-
renin hypertension has varied from 12 to 46 (Adlin, Marks & 
Channick, 1972; Brunner, Sealey& Laragh, 1973; Channick, 
Adlin & Marks, 1969; Crane, Harris & Nokus, 1972; Creditor 
& Loschky, 1967; Doyle & Jerums, 1970; Granger, Boucher & 
Genest, 1968; Gunnels, McGuffin, Robinson, Grim, Wells, 
Silver & Glenn, 1970; Helmer, 1965; Jerums & Doyle, 1969; 
Kloppenborg, Benraad, Drayer & Benraad, 1973; Ledingham, 
Bull & Laragh, 1967; Mroczek, Finnertv & Catt, 1973; Tuck, 
Williams, Cain, Sullivan & Dluhy, 1973) . To identify these 
low-renin patients widely differing tests have been used. 
Some investigators have- measured basal plasma renin activi-
ty whereas others have determined plasma renin activity or 
plasma renin concentrations after stimulation of renin 
secretion. When different tests have been used, however, it 
does not necessarily follow that the same patients will be 
identified as low- or normal-renin patients. 
A widely practised procedure is to measure plasma 
renin activity after stimulation by rigid sodium restriction 
and upright posture. This procedure, however, necessitates 
admission to hospital. For out-patient screening the res-
ponse of the plasma renin activity to an oral or intravenous 
dose of frusemide has been recommended (Carey, Douglas, 
Schweikert & Liddle, 1972; Channick et al., 1969; Dawson & 
Wallach, 1974; Jose & Kaplan, 1969; Kern, Kramer, Blend, 
Hemphill, Gomez-Sanchez, White & Kaplan, 1972; Rosenthal, 
Boucher, Nowaczynski & Genest, 1968). However, according to 
Brunner et al. (1973) this procedure is not sufficiently 
discriminating. 
In the present study we have measured the renin 
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response of hypertensive and normotensive subjects to sodium 
restriction under in-patient conditions. Plasma renin acti-
vity values collected in this way are compared with those 
obtained after two different procedures in which a diuretic 
drug was administered without restriction of sodium intake, 
to out-patients to determine whether these tests identify 
the same populations of normoreninaemic and hyporeninaemic 
patients. 
METHODS 
Patients. 
Fifty-eight hypertensive patients, whose diastolic 
blood pressure was, without therapy, above 95 mmHg, were 
admitted to hospital after antihypertensive treatment had 
been discontinued for at least 4 weeks. None of the patients 
had malignant hypertension, and renal and cardiac function 
was unimpaired. On the fifth day of controlled sodium 
restriction (15 mmol/24 h) peripheral venous blood for 
measurement of renin activity was taken at noon after 3 h 
of ambulation (PRA ). Eleven young normotensive control 
subjects, mean age 23.1 + 2.4 (SD) years, were subjected to 
a similar sodium restriction procedure. All were male, with 
a mean systolic blood pressure, measured after sodium re-
striction, of 122 + 8 mmHg and a mean diastolic blood 
pressure of 77 + 5 mmHg. 
The control subjects and a sub-group of twenty hyper-
tensive patients were studied as out-patients after stimu-
lation of renin activity with frusemide (Lasix). They con-
sumed a normal diet and were instructed to take three doses 
of frusemide orally, i.e. 0.12 mmol (40 mg) 18 h and 12 
h, and a last dose, 0.18 mmol (60 mg), 3 h before blood 
collection. The patients were ambulant during the last 3 h 
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before blood sampling at noon (PRAf). The mean age of the 
sub-group of twenty hypertensive patients was 40.0 + 8.9 
years; nine of them were female and eleven were male. The 
mean systolic blood pressure, measured after sodium restric-
tion, was 177 + 21 mmHg and the mean diastolic blood pres-
sure 111 + 28 mmHg. 
After studying the results of renin stimulation with 
frusemide, plasma renin activity was measured in the same 
control subjects and in a sub-group of thirty-eight hyper-
tensive out-patients after stimulation with chlorthalidone 
(Hygroton). After a daily intake of 0.3 mmol (100 mg) of 
chlorthalidone for 5 days, during which period the patients 
were on a normal diet, blood was taken at noon, again after 
3 h of ambulation (PRA ). The mean age of the sub-group 
was 4 2.6 + 12.8 years; twenty-four of them were female and 
fourteen were male. The mean systolic blood pressure, 
measured after sodium restriction, was 166 + 24 mmHg and 
the mean diastolic blood pressure was 110 + 15 mmHg. The 
sub-groups of hypertensive patients did not differ signifi-
cantly in respect of mean age, sex or blood pressure. 
In ten of the normotensive control subjects plasma 
renin activity was measured on the third, sixth and seventh 
day as well as on the fifth day of chlorthalidone medication. 
In eight hypertensive patients renin activity was 
measured on the fifth day of chlorthalidone treatment and 
after long-term medication (more than 42 days) with chlor-
thalidone alone. Blood for renin measurements was collected 
at noon after 3 h of ambulation. During chlorthalidone 
medication the control subjects and the hypertensive 
patients were on a normal diet. 
The hypertensive patients were chosen on a random 
basis. Both normotensive control subjects and the hyperten-
sive patients gave their informed consent to the studies. 
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Analytical methods. 
In this study, plasma renin activity (PRA) is defined 
as the amount of angiotensin I formed after an incubation 
procedure as described by Boucher, Veyrat, de Champlain & 
Genest (1964). Blood for renin measurement was collected in 
ice-cooled containers. EDTA was used as an anticoagulant. 
The amount of angiotensin I in the eluate of the Dowex 
column was measured by radioimmunoassay. 
The antiserum was raised in a rabbit against angio-
tensin I. Final antiserum dilution was 1 : 1 100 000. 
Iodinated angiotensin I, obtained from Sorin (I.R.E. Mol 
Belgium), was used without further purification. Standard 
angiotensin I was obtained from Schwarz Mann, Orangeburg, 
New York. The assays were carried out by means of a double-
antibody solid-phase technique. This method of PRA measure-
ment has an intra-assay variation of 7.8 - 9.1 % and an 
interassay variation of 10.4 - 15.0 % for different renin 
activities. The recovery of angiotensin I was 108 + 11 %. 
Plasma electrolytes were measured by flame photometry 
with internal standard. 
Non-parametric statistical methods were used to detect 
differences between two groups (Wilcoxon's two-sample test) 
and to calculate correlation coefficients between variables 
(Spearman's correlation coefficient r). Results are expressed 
as means + SD. 
RESULTS 
Plasma renin activity in normotensive control subjects. 
The mean of the PRA values after sodium restriction 
(PRAsr) (19.0 + 10.0 nmol.3h-1.l_1) did not differ signifi-
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PRA, PRA 5 Γ PRA chi 
Fig. 1. RELATION BETWEEN PRA . PRA, AND PRA . , IN 11 3
 sr f chi 
NORMOTENSIVE CONTROL SUBJECTS. 
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F i g . 2 . RELATION BETWEEN PRA AND PRA f IN 20 PATIENTS 
WITH HYPERTENSION. 
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cantly from the mean of those after frusemide (PRA,) 
-1 -1 (16.6 + 5.3 nmol .3 h .1 ), but was highly significantly 
(P< 0.005) different from the mean of those after chlor­
thalidone (PRA
 h l ) (45.8 + 18.8 nmol.3 h"
1
.!"1) (Fig. 1). 
It should be noted that the effect of frusemide stimulation 
is variable, as five PRA, values are equal to or lower than, 
and six are higher than, PRA values. By contrast, the 
PRA , , values were consistently higher than the correspon­
ding PRA _ and PRA, values. One of the PRA values in the 
sr f sr 
normotensive control group was below the normal range 
measured in a larger group of normotensive subjects. The 
corresponding PRA ,, value was also lower than that of the 
other subjects, whereas his PRA, value falls within the 
range of the other ten normotensive controls. 
Plasma renin activity in hypertensive patients. 
The mean of the PRA values (20.7 + 14.7 nmol.3 h _ 1. 
-1 s r 
1 ) did not differ significantly from the mean PRA, value 
(15.5 + 8.7 nmol.3 h _ 1.l - 1) (Fig. 2). The correlation 
between PRA and PRA, was not significant (r = + 0.29, 
sr f ^ 
η = 20, Ρ > 0.1). As in the normotensive controls there was 
no parallelism between the PRA and the corresponding 
PRA, values. The PRA, values of twelve patients were equal 
to or lower (remarkably lower in some) than their corres­
ponding PRA values, whereas in eight patients the PRA, 
values were higher than their PRA values. 
sr 
With the response to sodium restriction used as a 
criterion of low- and normal-renin hypertensive patients, 
the frusemide test resulted in misclassification in five 
cases. 
The mean of the PRA , , values (29.1 + 25.5 nmol. 
-1 -1 C h l 
3 h .1 ) was significantly (P< 0.001) higher than the 
50 
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Fig. 3. RELATION BETWEEN PRA AND PRA ., IN 38 PATIENTS 3
 sr chi 
WITH HYPERTENSION. ·, RESULTS FOR PATIENT WITH PRIMARY 
ALDOSTERONISM. 
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mean of the PRA values (12.3 + 11.0 nmol,3 h - 1 . l p l ) , and 
the PRA ... values were without exception higher than the 
corresponding PRA values (Fig. 3). In this group of 
thirty-eight patients there was a highly significant posi­
tive correlation between PRA , , and PRA (r = + 0.78, 
chi sr 
Ρ < 0.001) . 
If these hypertensive patients are divided into those 
with hyporeninaemia and those with normal plasma renin 
activity according to their PRA values, eighteen would 
belong to the first and twentv to the second group. The 
PRA , , values obtained in the first group ranged from 5.1 
to 18.8 nmol.3 h .1 , and in the second from 22.9 to 
121.4 nmol.3 h .1 . The difference,therefore, between the 
highest value in the low-renin group and the lowest value 
in the normal-renin group, was 4.1 nmol.3 h .1 , which was 
about 4.5-fold the difference of 0.9 nmol.3 h .1 between 
the highest PRA value in the low-renin group and the 
lowest PRA value in the normal-renin patients. Thus, with 
renin values after sodium restriction used as a criterion 
for low and normal renin, the chlorthalidone test did not 
misclassify any of the thirty-eight patients. 
Plasma renin activity after chlorthalidone treatment during 
various periods. 
To determine whether the duration of diuretic therapy 
was critical, plasma renin activity was measured in ten 
normotensive control subjects on the third, fifth, sixth 
and seventh davs of chlorthalidone medication. The mean 
PRA , , value on the third day was 29.6 + 16.2 nmol.3 h 
chi J — 
1 , significantly (P< 0.05) lower than the mean PRA , , on 
the fifth day (48.0 + 24.0 nmol.3 h _ 1 . l - 1 ) . PRA was measured 
in four subjects on the sixth day and in six subjects on the 
seventh day. In view of the small number of subjects these 
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PRA values were taken together. The mean PRA value thus 
obtained was lower (34.9 + 14.3 nmol,3 h .1 ) than that 
on the fifth day, but not significantly so. 
Renin activity was measured in eight hypertensive 
patients on the fifth day of chlorthalidone treatment and 
after long-term medication (more than 42 days) with chlor-
thalidone alone. The mean plasma renin activity on the fifth 
day was significantly (P< 0.03) higher (39.1 + 14.8 nmol. 
3 h-1.l~ ) than that after long-term treatment (19.2 + 14.5 
nmol.3 h .1 ). Indeed, five of the eight PRA values 
measured after long-term medication were in the range of 
the PRA , , values of the eighteen patients with low-renin 
hypertension and only one patient had a low PRA after 
chlorthalidone therapy for 5 days as well as after sodium 
restriction and upright posture. 
Plasma potassium values. 
In all normotensive subjects as well as in some of the 
hypertensive patients blood was taken for renin and plasma 
potassium determination. In the eleven normotensive control 
subjects the mean plasma potassium value was 3.83 + 0.51 
mmol/1 after 5 days of sodium restriction. After frusemide 
administration the mean potassium value was lower (3.77 + 
0.26 mmol/1) but not significantly so. After 5 days of 
chlorthalidone treatment the mean potassium value was sig-
nificantly (P< 0.005) lower than after both the sodium 
restriction and the frusemide test (3.23 + 0.26 mmol/1). 
In twenty-five hypertensive patients the mean plasma 
potassium value after chlorthalidone medication for 5 days 
was 3.08 + 0.42 mmol/1; this was significantiv (P< 0.005) 
lower than that after sodium restriction in these patients 
(4.04 + 0.41 mmol/1) and also significantly (P< 0.05) lower 
than the mean nlasma potassium value in nine patients after 
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frusemide (3.59 + 0.45 mmol/1). 
Adverse reactions. 
After frusemide severe adverse reactions were noted in 
four subjects, i.e. severe tetany, hypotension, fainting 
and severe hypokalaemia (1.9 mmol/1). The patient with 
severe hypokalaemia had low potassium values (less than 
3.0 mmol/1) before treatment. After chlorthalidone medica-
tion the lowest plasma potassium observed was 2.4 mmol/1. 
This patient had no complaints during this test. This 
patient had low PRA and hyperaldosteronism. At operation an 
adenoma of one adrenal was found. In the other patients 
with low-renin hypertension no evidence of primary aldoste-
ronism was found. 
Milder complaints were noted in four other patients 
(nausea, vomiting, dyspnoea and tiredness). Adverse reactions 
were thus noted in eight of the thirty-five frusemide tests. 
Chlorthalidone was administered fifty-four times; one sub-
ject complained of mild tetany, one of dizziness and some 
about tiredness. No severe adverse reactions were noted. 
DISCUSSION 
Carey et al. (1972) used frusemide in three doses over 
a period of 18 h and observed two separate groups of hyper-
tensive patients, one of which had suppressed and the other 
normal plasma renin activity. The present studv, using 
practically the same procedure as Carey, yielded PRA values, 
which, in twelve out of twenty hypertensive patients and 
seven out of eleven normotensive control subjects, were 
equal to or lower than the corresponding PRA values after 
sodium restriction. 
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This unpredictable effect of frusemide has also been 
noted by Brunner et al. (1973), who observed lack of renin 
response after intravenous administration of frusemide in 
a number of hypertensive patients and did not regard this 
test as adequate for the identification of renin sub-groups. 
A subnormal response to a single oral dose of frusemide 
with a normal increase of renin activity after sodium 
restriction has also been observed by Channick et al. 
(1969) and Adlin et al. (1972). Conversely,patients with 
subnormal response to sodium restriction may respond nor-
mally to a single dose of frusemide (Channick et al., 1969). 
The data reported in this study and those reported by 
Channick et al. (1969) clearly indicate that the frusemide 
test does not discriminate the same population of 'low-
renin' patients as the sodium restriction test. By contrast 
all the PRA values obtained from hypertensive patients and 
control subjects after chlorthalidone medication (PRA ,,) 
are higher than the corresponding renin values measured 
after sodium restriction (PRA ). Furthermore, all hyper-
tensive patients who, according to their renin values on 
sodium restriction, are classified as 'low-renin hyperten-
sive' show PRA , , values which are lower than the lowest 
cnl 
PRA . , value measured in the normal PRA group. All the 
chi sr 3 r 
PRA , , values of the low PRA hypertensive patients are chi sr r r lower than the PRA , , values measured in the normotensive 
chi 
control subjects with a normal PRA . It should be added 
sr 
that in both normotensive control subjects and in hyperten-
sive patients the number of days of treatment with chlor-
thalidone is of importance. Thus plasma renin activity after 
long-term chlorthalidone administration was significantly 
lower than after the chlorthalidone test. This may be of 
relevance in the controversy surrounding the renin response 
to long-term diuretic therapy. 
Our findings indicate that this out-patient test 
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discriminates the same population of hyporeninaemic patients 
as does the most widely accepted clinical test in which a 
rigidly controlled low sodium diet is combined with 3 h of 
ambulation. 
To define a normal range of PRA , , values it is 
necessary to measure this variable in a larger sample of 
normotensive control subjects, closely matched to the hyper­
tensive population. This study is now proceeding in our la­
boratory. 
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SUMMARY 
The use of renin stimulation with chlorthalidone to 
detect low-renin hypertension has been further evaluated in 
this study. The classification of patients, according to the 
chlorthalidone test, as low- or normal-renin hypertensives 
has been compared with the classification of the same 
patients according to the plasma renin activity measured 
after a moderate, normal or high sodium intake. 
In 60 patients, the data of 38 of them have been 
reported in a previous study, the plasma renin activity was 
measured both after the chlorthalidone test as well as 
after sodium restriction in hospital. Two patients were 
misclassified as low- or normal-renin according to one of 
the tests. 
The patients with low plasma renin activity after 
chlorthalidone did not have lower renin values after a 
moderate, unrestricted or high sodium intake than those with 
normal renin activity after chlorthalidone. Moreover, the 
plasma renin activities found after a moderate or unrestric-
ted sodium intake in these low-renin patients, were all 
within the range of the renin values found in normotensive 
control subjects after a comparable sodium intake. 
The chlorthalidone test is a reliable out-patient 
procedure for the detection of low-renin hypertension. The 
test is a useful substitute for the in-patient sodium 
restriction test. 
Dividing hypertensive patients in hypo- and normo-
reninemics according to the plasma renin activity measured 
after a moderate or high sodium intake resulted in a 
classification, radically different from that obtained with 
the chlorthalidone test. Adequate renin stimulating 
maneuvers are needed for a reliable identification of a low-
renin state. 
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INTRODUCTION 
As was mentioned earlier, widely differing tests have 
been used to identify low-renin patients (1). Some investi-
gators used a procedure in which renin secretion is stimu-
lated by ambulation without sodium depletion (2 - 6). 
Brunner et al (7) related the plasma renin activity (PRA) 
measured after ambulation without sodium restriction or 
depletion to urinary sodium excretion. Other investigators 
used more rigorously stimulating methods as either sodium 
restriction (8 - 17) or pharmacologically induced stimula-
tion of renin secretion by furosemide (18 - 20), diazoxide 
(21) or hydralazine (22). 
The low-renin discriminating capacity of three renin 
stimulating maneuvers has been compared in a previous study 
(1). Controlled dietary sodium restriction and short-term 
chlorthalidone medication appeared to detect the same hyper-
tensive individuals as low-renin patients. Administration of 
furosemide did not identify the same patients as low-renin 
hypertensives as did the two other procedures. 
In this study the results of the chlorthalidone 
procedure have been compared with the results of renin 
measurements in normotensive and hypertensive subjects on 
moderate,unrestricted and high sodium intake. 
METHODS 
First, in 22 hypertensive patients (11 male and 11 
female, age range from 21 - 57 years), the PRA measurements 
after short-term chlorthalidone medication were compared 
with the PRA measured after 5 days of controlled sodium 
restriction in hospital. The study design has been described 
earlier (1). 
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Secondly, the PRA was measured in 22 normotensive 
(diastolic blood pressure lower than 90 mmHg) control sub-
jects (12 females, 10 males age range 17 to 55 years) at 
noon after normal activity in the morning hours. Thereafter 
the PRA was measured on the fifth day of chlorthalidone 
medication (100 mg per day at 8.00 a.m.) again at noon 
after 3 h of ambulation. These subjects (hospital personnel 
and their relatives) consumed a normal diet. The urinary 
sodium excretion was measured in urine collected during the 
24 hours previous to blood sampling for PRA. Using the same 
two tests, PRA measurements were also done in 15 hyperten-
sive (diastolic blood pressure higher than 90 mmHg) patients 
(7 females, 8 males, age range 25 to 58 years). In a second 
group of hypertensive patients (8 females, 7 males, age 
range 32 to 58 years) the results of the chlorthalidone test 
were compared in the same way with renin measurements after 
five days during which an unrestricted sodium diet was sup-
plemented with 150 mEq sodium chloride in divided doses 
orally. All these hypertensive patients were off antihyper-
tensive treatment for at least four weeks. 
The PRA was measured by radioimmunoassay (23). 
A non parametric test was used to calculate correlation 
coefficients (Spearman's rank correlation test). The results 
are expressed as means + SD. 
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RESULTS 
Comparison of PRA values measured after sodium restriction 
(15 mEq/24 h) with those measured after the chlorthalidone 
test in 22 patients with benign essential hypertension. 
According to the PRA measured after sodium restriction 
and chlorthalidone in normotensive control subjects (Table 1) 
5 of 22 hypertensive patients had low-renin values after 
sodium restriction (range 4.4 to 10.9 ng.ml 1.3 h 1) and 17 
had a normal PRA (range 11.5 to 40.6 ng.ml !.3 h ')· In four 
of these low-renin hypertensives the PRA measured after 
chlorthalidone was lower than the lowest PRA found in the 
control subjects (range 7.5 to 25.0 ng.ml '.3 h ')· The 
fifth patient, with a PRA after sodium restriction of 10.9 
ng.ml l .3 h 1, had a PRA after chlorthalidone within the 
range of the normotensive subjects (34.7 ng.ml '.3 h l). 
All but one of the 17 hypertensive patients with a PRA after 
sodium restriction within the range of the normotensive 
subjects, had normal PRA values after chlorthalidone (range 
26.9 to 85.0 ng.ml_1.3 h _ 1 ) . One patient had a normal PRA 
after sodium restriction (13.1 ng.ml '.3 h ') and a low 
renin value after chlorthalidone (20.1 ng.ml"1.3 h _ 1 ) . 
Comparison of PRA values measured after an unrestricted 
sodium diet with those after the chlorthalidone test in 22 
normotensive control subjects. 
The PRA values measured after the chlorthalidone test 
in 22 normotensive control subjects ranged from 26.9 to 
100.0 ng.ml_1.3 h~*, mean 48.4 + 21.2 ng.ml_1.3 h"1. The 
corresponding PRA values without chlorthalidone were on 
average 5.7 + 4.6 ng.ml_1.3 h_1with a range from 1.4 to 
20.6 ng.ml ' . 3 h 1 (Fig. 1). The correlation between PRA 
values measured after both procedures was highly signifi-
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"ig. 1. COMPARISON OF PRA AFTER CHLORTHALIDONE WITH PRA 
,FTER AN UNRESTRICTED SODIUM INTAKE IN 2 2 NORMOTENSIVE 
ONTROL SUBJECTS. 
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Table 1. RANGES OF PLASMA RENIN ACTIVITIES MEASURED AFTER 
3 H OF AMBULATION AT NOON AND OF THE URINARY SODIUM EXCRE­
TION DURING 24 HOURS STARTING AT NOON ON THE PREVIOUS DAY 
IN NORMOTENSIVE CONTROL SUBJECTS. 
SODIUM RESTRICTION 
TEST η = 26 
CHLORTHALIDONE 
TEST η = 22 
UNRESTRICTED SODIUM 
DIET η = 22 
PRA 
ng.ml 1.3 h 1 
11.5- 59.5 
26.9 - 100.0 
1.4 - 20.6 
URINARY SODIUM 
EXCRETION 
mEq/24h 
2 - 2 0 
78 - 320 
67 - 284 
cantly positive (r = 0.70, ρ < 0.001). The PRA values in 
normotensive control subjects after controlled sodium re­
striction in hospital, after an unrestricted sodium intake 
and after the chlorthalidone test on an out-patient base are 
shown in table 1 with the urinary sodium excretion during 
the 24 hours previous to the renin measurement. 
Comparison of PRA values after moderate sodium intake (115 
mEq/24h) in hospital or on an out-patient base with unrestric­
ted diet with those after the chlorthalidone test in 15 
hypertensive patients. 
After moderate sodium intake the PRA values ranged from 
1.4 to 11.6 ng.ml ' .3 h 
PRA was measured in 
the PRA ranged from 1.5 to 11.6 ng.ml-'.3 h~'and in the 7 
1
. In the 8 patients in which the 
hospital on moderate sodium intake 
patients with unrestricted sodium intake on an out-patient 
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100 
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20 
PRA after 
chlorthalidone 
ng-m|-1.3h-1 
г 4 0 
PRA after 
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unrestricted 
sodium intake 
30 
20 
-10 
Fig. 2. COMPARISON OF PRA AFTER CHLORTHALIDONE WITH PRA 
AFTER MODERATE OR UNRESTRICTED SODIUM INTAKE IN 22 
HYPERTENSIVE PATIENTS. THE SHADED AREA REPRESENTS THE 
RANGE IN NORMOTENSIVE CONTROL SUBJECTS. 
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Fig. 3. COMPARISON OF PRA AFTER CHLORTHALIDONE WITH PRA 
AFTER SODIUM LOADING IN 15 HYPERTENSIVE PATIENTS. THE SHADED 
AREA REPRESENTS THE RANGE IN NORMOTENSIVE CONTROL SUBJECTS. 
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base from 1.4 to 9.1 ng.ml s.3 h *. The corresponding renin 
activities after the out-patient chlorthalidone test ranged 
from 8.4 to 85.0 ng.ml-1.3 h_1(Fig. 2). 
Five out of these 15 patients had PRA values after 
chlorthalidone lower than the lowest value found in normo-
tensive control subjects (range 8.4 to 25.3 ng.ml ^3 h !)· 
The PRA values measured on moderate or unrestricted sodium 
intake in these 5 patients were all within the range of the 
values measured on an unrestricted sodium intake in normo-
tensive control subjects (range 1.5 to 7.4 ng.ml '.3 h ' ) . 
The correlation coefficient between the corresponding PRA 
values measured after both procedures in this group of 
hypertensive patients was not significant (r = 0.34, ρ > 0.1). 
Comparison of PRA values after sodium loading with those 
after the chlorthalidone test in 15 hypertensive patients. 
In this group of patients the PRA measured after sodium 
loading (unrestricted sodium intake and 150 mEq of sodium 
chloride per day in addition) ranged from 0.6 to 8.6 
ng.ml 1.3 h ' and the corresponding PRA values after chlor­
thalidone from 14.5 to 85.0 ng.ml_1.3 h_1(Fig. 3). 
Three out of these 15 patients had PRA values after 
chlorthalidone lower than the lowest value found in normo-
tensive control subjects (14.5, 21.9 and 26.8 ng.ml '.3 h M . 
The corresponding renin values measured after sodium loading 
were 8.1, 2.0 and 1.9 ng.ml '.3 h ' respectively). The two 
patients with the lowest renin values after sodium loading 
(0.6 and 1.0 ng.ml 1.3 h 1) had normal renin values after 
chlorthalidone (53.8 and 34.7 ng.ml '.3 h ' respectively). 
The correlation coefficient between the corresponding PRA 
values measured after both procedures in this group of 15 
hypertensive patients was not significant (r = - 0.03, 
ρ > 0.1) . 
70 
DISCUSSION 
The frequency at which low renin hypertension has been 
reported to occur differs widely, from 12 - 46 % (1). To 
explain this wide range at least two questions have to be 
answered. First/ what is the range of renin values in 
normotensive control subjects under comparable circumstances 
and secondly, do all tests indeed identify the same patients 
as low-renin hypertensives. In a previous study of this 
laboratory (1) at least the chlorthalidone test and the 
sodium restriction test appeared to identify the same 
patients as low-renin or normal-renin hypertensives. Divi-
ding a group of hypertensive patients according to the 
furosemide test a radically different subclassification was 
obtained in that study. 
In this study the range of PRA values in a relatively 
small sample of normotensive control subjects has been 
given for the sodium restriction test and the chlorthali-
done test. The range of renin values in normotensive control 
subjects as well as in hypertensive patients is well known 
to vary widely. Therefore, accepting a range from observa-
tions in a relatively small number of subjects or patients 
is rather arbitrary. With these limitations in mind, the 
given ranges have been used to classify hypertensive 
patients in hypo- and normo reninemics. From the results 
obtained in an earlier study (1), none of 38 hypertensive 
patients were misclassified by either test. In the additio-
nal 22 hypertensive patients, in this study 20 of the 22 
patients again showed renin values after either method in 
the low or normal range. Therefore, in 58 out of 60 patients 
the same classification as hypo- or normo reninemics was 
obtained by both the sodium restriction as well as the 
chlorthalidone test. One of the remaining two patients had 
a PRA after sodium restriction (10.9 ng.ml '.3 h M just 
71 
below the normal range and a PRA after chlorthalidone 
(34.7 ng.ml-1.3 h _ 1) in the lower part of the range in 
normotensive control subjects. The other patient had a just 
normal PRA after sodium restriction (13.1 ng.ml '.3 h ') 
and a PRA after chlorthalidone of 20.1 ng.ml 1.3 h _ 1, 
slightly lower than the lowest value found in normotensive 
control subjects (26.9 ng.ml_1.3 h M . The correlation 
coefficient between the renin values obtained in either 
procedure was as high as + 0.77 (n = 60, ρ < 0.001). The 
correlation coefficient between the results of both proce­
dures in the earlier report (1) was +0.78! (n = 38, ρ < 
0.001) . 
From the results depicted in Fig. 2 and 3 it appears 
that, neither after a moderate or normal sodium intake, 
nor after sodium loading, the same patients were identified 
as hypo- or normoreninemics as with the chlorthalidone 
test. Moreover, there appeared to be a huge overlap between 
the range of renin values measured in normotensive control 
subjects after an unrestricted sodium intake and the range 
found in - according to the chlorthalidone test - low-renin 
hypertensive patients after a moderate, an unrestricted or 
even a high sodium intake. 
This study therefore confirms the conclusion of an 
earlier study in this laboratory (1), that the chlorthalidone 
test is a reliable out-patient procedure to detect low-renin 
hypertension. In addition it has been shown that this test, 
as well as the in-patient sodium restriction test give a 
radically different renin subclassification than that 
obtained by measuring the PRA in hypertensive patients on a 
moderate, an unrestricted or a high sodium intake. Therefore, 
in order to discriminate relative suppression of renin 
activity an adequately stimulating procedure seems necessary. 
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SUMMARY 
In this study blood pressures measured by auscultation 
with a standard sphygmomanometer were compared with blood 
pressures recorded with an automated device. In the first 
part of the study the systolic blood pressure was measured 
simultaneously by auscultation and the automated device. 
The difference between both readings was not significant and 
a highly significant positive correlation was found between 
both systolic blood pressures. 
However, because of the absence of a physician or nurse 
during the automated blood pressure recordings, the blood 
pressures recorded during 40 minutes of recumbency were sig­
nificantly lower than the pressures measured by auscultation 
during another 40 minutes of recumbencv, irrespective of the 
sequency of these maneuvers. 
The mean of the systolic and diastolic blood pressures 
recorded during 30 minutes of recumbency were both in 
hypertensive patients and normotensive control subjects 
about 7 % lower than the corresponding casual blood pressu­
res. The lowest systolic and diastolic blood pressure 
recorded during that period was in patients and control 
subjects ajr^ out 12 % lower than the casual auscultatory 
blood pressure. 
A more marked decrease in systolic and diastolic blood 
pressure was observed during the night. The lowest systolic 
blood pressure recorded during the night in hypertensive 
patients and normotensive control subjects was about 32 % 
lower than the casual systolic blood pressure at day-time. 
With regard to the diastolic blood pressures, the relative 
decrease was significantly less in the hypertensive patients 
than in the control subjects (26 and 35 % respectively, 
ρ < 0.003). 
The variability of the blood pressure was defined as 
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the difference between the day-time casual blood pressure, 
measured by auscultation, and the lowest blood pressure 
recorded at night with the automated device. 
The variability was not significantly correlated with 
the age of the normotensive control subjects or the hyper-
tensive patients. In the group of patients with benign 
essential hypertension a loose though significant negative 
correlation was calculated between the plasma renin activi-
ty and the variability of the blood pressure. 
From the correlation coefficients found in normotensive 
control subjects and hypertensive patients between the 
casual blood pressure at day-time, the lowest blood pressure 
recorded at night and the variability, the conclusion seemed 
inevitable that the casual systolic and diastolic day-time 
blood pressure levels in normotensive control subjects are 
per se more varying qualities than those in hypertensive 
patients. 
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INTRODUCTION 
The use of an automatic blood pressure monitor prevents 
observer's bias in the evaluation of blood pressure responses 
to different stimuli or therapeutic regimens. Moreover, 
errors as terminal digit preference are overcome. However, 
these and other measurement errors account for only a minor 
part of the total variability of the results of assessing 
the blood pressure. The factors inducing a greater variabi-
lity in blood pressure measurement include environmental con-
ditions; e.g. the reported differences between the casual and 
basal blood pressure and the blood pressure decrease during 
sleep (1, 2, 3) . 
The significance of the total variability or 'response 
instability' of the diastolic blood pressure has been shown 
clearly by Varady and Maxwell (4). These investigators collec-
ted data on the diastolic blood pressure by standard manome-
try in 2442 hospitalized patients with mean diastolic blood 
pressures ranging from 60 to 178 mmHg (about 27.000 measure-
ments) . The blood pressure was taken four times daily, during 
three days, by different observers. The range of the diffe-
rences found in the whole group between the lowest and 
highest diastolic blood pressure measured in each patient 
ranged from 0 to 90 mmHg with a mean of 31 mmHg. 
In order to assess the variability of the blood 
pressure as a physiological phenomenon and to study the 
antihypertensive effect of different pharmacological agents 
an automated device, excluding observer's bias and terminal 
digit preference, would be of great value. In this study 
blood pressurés measured by standard manometry and with an 
automated device have been compared. 
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METHODS 
The automatic blood pressure monitor used was the 
Arteriosonde 1216 (Roche Medical Electronics Division, 
Hoffmann - La Roche Inc., Orangeburg, N.Y., U.S.A.). With 
this device systolic and Korotkoff, fourth-phase diasto­
lic pressures are measured with ultrasound detection of 
pulsatile movements of the brachial artery wall as it is 
relieved from compression by a pneumatic cuff. The results 
p_ 
are recorded as point plots on a connected Arteriocorder 
1508. 
A portable model of a standard mercury sphygmomano­
meter, Erkameter 300, was used to measure the blood 
pressure by auscultation. Fourth phase diastolic blood 
pressures were read. 
In ten normotensive volunteers the blood pressure was 
measured by standard manometry as well as by automatic re­
ti 
cording with the Arteriosonde . By each procedure the blood 
pressure was taken every ten minutes during one of two 
successive hours of recumbency at day-time. In five subjects 
the blood pressure was measured by auscultation during the 
first hour and recorded with the Arteriosonde in the second 
hour, and in the remaining subjects the reverse sequence was 
followed. The physician, present for measuring the blood 
pressure by stethoscope, left the room during the period of 
automatic blood pressure recording. The mean blood pressure 
found during the last forty minutes of each procedure were 
averaged and the differences between these values tested 
for significance. Before and after each period of automatic 
blood pressure recording, the blood pressure was measured 
simultaneously, by both methods, three times, by placing a 
ρ 
stethoscope just below the cuff of the Arteriosonde . With 
this procedure only the systolic pressures can be compared, 
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because after recording the diastolic blood pressure the 
cuff deflates too rapidly to measure the diastolic blood 
pressure reliably with the stethoscope. 
In 15 normotensive control subjects, (casual blood 
pressure < 90 mmHg, 4 male and 11 female, ranging in age 
from 25 to 67 years, mean 38.7 + 12.8 years) and 19 
patients with benign essential hypertension, (casual blood 
pressure, off treatment > 95 mmHg, 9 male and 10 female, 
ranging in age from 21 to 58 years, mean 43.4 + 10.4 years) 
the blood pressure was measured during 45 minutes of recum-
bency. In the middle of the first 15 minutes the blood 
pressure was measured by standard auscultatory manometry 
and during the last 30 minutes the blood pressure was 
recorded every 5 minutes with the Arteriosonde . During the 
blood pressure recording the subjects and patients were 
lying supine and left alone. The blood pressure level 
measured by auscultation in the first 15 minutes was compared 
with the mean of the blood pressures recorded during the 
last 30 minutes and with the lowest systolic and diastolic 
blood pressure recorded during the same period. These lowest 
blood pressures recorded were considered to represent the 
basal blood pressure as described by Freis (5), with the 
modification that in this study the blood pressure was 
measured automatically in the absence of a nurse or 
physician. 
In 17 normotensive control subjects, 9 male and 8 
female, age range 21 - 65 years (39.4 + 17.1 years) and in 
34 patients with benign essential hypertension, 15 male 
and 19 female, age range 20 - 61 years, (39.8 + 12.2 years) 
the blood pressures were measured with the Arteriosonde 
during the night (from about 11 p.m. to about 6 a.m.) 
every half an hour. The mean of the blood pressures recor-
ded during the night and the lowest systolic and diastolic 
blood pressure recorded during the same period were compared 
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with the mean of two or three casual blood pressures measu­
red by standard manometry during day-time. All, normoten-
sive subjects and hypertensive patients had about equal 
intake of sodium and the blood pressure study was performed 
after they were accomodated to the hospital situation. In 
all of these 34 hypertensive patients the plasma renin 
activity (PRA) was measured after 5 days of controlled 
sodium restriction (sodium intake 15 mEq/24 h) and 3 h of 
ambulation. The PRA was measured by radioimmunoassay (6). 
Non-parametric statistical tests were used to detect 
differences between paired or unpaired observations 
(Wilcoxon's test) and to calculate correlation coefficients 
(Spearman's rank correlation test). The results are expressed 
as means + standard deviation. 
RESULTS 
Calibration. 
From the data of the experiment in which the systolic 
blood pressure was measured simultaneously by auscultation 
and with the Arteriosonde , a highly significant positive 
correlation was calculated between both blood pressures 
(Fig. 1, r = 0.99, η = 60, ρ < 0.001). The systolic blood 
pressures measured by auscultation were slightly and not 
significantly higher than those measured with the Arterio­
le 
sonde ; 0.9+0.9 mmHg. In none of the simultaneous 
measurements the diastolic blood pressure measured by 
auscultation was higher than that recorded bv the Arterlo-
sonde . 
By comparing the mean of the blood pressures measured 
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Auscultation — 
Systolic blood 
pressure mm Hg 
150 η 
140 -
130 
1 2 0 -
110 
100 
9 0 -
r = 0 99 
π = 60 
p<0 001 
— ι — 
90 100 110 120 130 140 150 
Systolic blood pressure mmHg 
Artenosonde® 
Fig. 1. CORRELATION BETWEEN SYSTOLIC BLOOD PRESSURES 
MEASURED SIMULTANEOUSLY BY AUSCULTATION AND WITH THE 
ARTERI0S0NDER. 
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every 10 minutes during the last 40 minutes of each of 2 
successive hours of recumbency by auscultation and with the 
Arteriosonde , significantly lower blood pressures, both 
systolic and diastolic, were recorded with the latter 
method (Table 1), irrespective of the sequence of the 2 
methods. The correlation between the mean of the systolic 
blood pressures measured by manometry and the mean of the 
systolic blood pressures recorded with the Arteriosonde was 
significantly positive (r = 0.75, ρ > 0.05) as was the corre­
lation between both mean diastolic blood pressures (r = 0.70, 
ρ < 0.05). 
Table 1. COMPARISON OF BLOOD PRESSURE LEVELS MEASURED IN THE 
SAME NORMOTENSIVE CONTROL SUBJECTS BY AUSCULTATION AND WITH 
THE ARTERIOSONDER DURING THE LAST 4 0 MINUTES OF EACH OF 2 
SUCCESSIVE HOURS OF RECUMBENCY. 
AUSCULTATION 
SYSTOLIC BLOOD 
PRESSURE mmHg 119 + 11 
DIASTOLIC BLOOD 
PRESSURE mmHg 7 6 + 7 p < 0 . 0 5 6 9 + 9 
Comparison of casual blood pressures measured by standard 
manometry and blood pressures recorded with the Arteriosonde 
at day-time. 
In 19 hypertensive patients and 15 normotensive control 
subjects the casual blood pressures measured by auscultation 
after 5 to 10 minutes of recumbency were compared with the 
blood pressures recorded during the following 30 minutes, 
every 5 minutes, with the Arteriosonde" , the patient 
ARTERIOSONDE 
ρ < 0.05 111 + 10 
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Table 2. COMPARISON OF SINGLE CASUAL BLOOD PRESSURES, MEASURED BY AUSCULTATION AFTER 5 TO 10 MINUTES 
OF RECUMBENCY, WITH THE MEAN OF THE BLOOD PRES5URES RECORDED WITH THE ARTERIOSONDE" DURING 30 MINUTES 
OF RECUMBENCY WITH 5 MINUTE INTERVALS, AND THE LOWEST BLOOD PRESSURE REACHED IN THAT PERIOD. 
systolic 
CASUAL 
diastolic 
systolic 
ARTERIOSO?«) E 
MEAN 
diastolic 
systolic 
ARTERIOSONDE 
LOWEST 
diastolic 
NORHOTENSIVE SUBJECTS 
η - 15 
ABSOLUTE VALUE 
mmHg 
121 + 9 
76 + 6 
m + 9 
72 + 7 
106 + 9 
6Θ + θ 
RELATIVE DECREASE 
IN % OF CASUAL 
READING 
: 
β + б 
7 + 7 
13 + 7 
12 + 7 
HYPERTENSIVE PATIENTS 
η » 19 
ABSOLUTE VALUE 
mmHg 
158 + 14 
104 + 11 
143 + 12 
9 6 + 9 
135 + 16 
9 1 + 9 
RELATIVE DECREASE 
IN « OF CASUAL 
READING 
: 
β + β 
6 + 5 
12 + 6 
1 1 + 6 
Table 3. CORRELATION COEFFICIENTS BETWEEN THE SINGLE CASUAL BLOOD 
PRESSURE READING, THE MEAN OF THE BLOOD PRESSURES RECORDED WITH THE 
ARTERIOSONDER DURING 30 MINUTES OF RECUMBENCY AT 5 MINUTE INTERVALS, 
AND THE LOWEST BLOOD PRESSURES REACHED IN THAT PERIOD. 
SYSTOLIC BLOOD PRESSURE RECORDED WITH THE ARTERIOSONDER 
CASUAL 
SÏSTOLIC 
BLOOD PRESSURE 
ARTERIOSONDER 
LOWEST SYSTOLIC 
BLOOD PRESSURE 
HYPERTENSIVE PATIENTS 
η - 19 
MEAN 
0.67* 
0.93* 
LOWEST 
0.75* 
-
NORMOTENSIVE SUBJECTS 
η = 15 
MEAN 
0.61"· 
0.92* 
LOWEST 
0.63·· 
-
DIASTOLIC BLOOD PRESSURE RECORDED WITH THE ARTERIOSONDER 
CASUAL 
DIASTOLIC 
BLOOD PRESSURE 
ARTERIOSONDE" 
LOWEST DIASTOLIC 
BLOOD PRESSURE 
HYPERTENSIVE PATIE, TS 
η = 19 
MEAN 
0.72· 
0.95· 
LOWEST 
0.71· 
-
NORMOTENSIVE SUBJECTS 
η = 15 
MEAN 
0.87· 
0.97· 
LOWEST 
0.77* 
-
• Ρ < 0.001 
·· Ρ < 0.01 
•·*Ρ < 0.05 
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being alone in the same silent room. 
In table 2 the means of the casual manometer readings, 
ρ 
the mean pressures recorded with the Arteriosonde and the 
lowest systolic and lowest diastolic blood pressures recor­
ded have been tabulated. Both in the normotensive control 
subjects and in the hypertensive patients, the mean of the 
blood pressures recorded with the Arteriosonde was signifi­
cantly (p < 0.01) lower than the mean of the casual blood 
pressures. The relative decreases in both, the hypertensive 
patients and the normotensive control subjects, were about 
equal. 
The correlation coefficients calculated between these 
blood pressures are shown in table 3. Both in the hyper­
tensive patients and in the normotensive control subjects a 
significant positive correlation was found between the casual 
blood pressures and the mean and lowest blood pressures 
recorded with the Arteriosonde . The highest correlation 
coefficients were found between the mean and the lowest 
blood pressures recorded with the automated device. 
Comparison of day-time casual blood pressures measured by 
standard sphygmomanometry with blood pressures recorded at 
night with the Arteriosonde . 
In 17 normotensive control subjects and 34 patients 
with benign essential hypertension data have been obtained 
according to the protocol described in the methods section. 
The results are depicted in table 4. Day-time casual blood 
pressure values are compared with the means of the blood 
pressure values obtained during the night and with the 
lowest value reached during this period. The systolic and 
diastolic blood pressures decreased significantly in both 
groups during the night (p < 0.001). The table also illustra­
tes that the relative decrease to the mean and lowest 
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systolic and to the mean diastolic blood pressure during the 
night was not significantly different between the normoten-
sive control subjects and the hypertensive patients. The 
relative decrease to the lowest diastolic blood pressure was 
slightly though significantly lower in the hypertensive 
patients (p < 0.003) than in the normotensive controls. 
Variability of the blood pressure derived from casual day-
time manometry and Arteriosonde blood pressure recording 
during the night and its relation to age and plasma renin 
activity. 
The difference between the mean of the blood pressures 
found at day-time by repeated manometry and the lowest blood 
pressures recorded with the Arteriosonde during the night 
is arbitrarily defined as a measure of the variability of a 
person's blood pressure. Tables 5 and 6 present the corre-
lation coefficients between the systolic and the diastolic 
casual blood pressures at day-time, the lowest systolic and 
diastolic blood pressures during the night, the differences 
between the respective systolic and diastolic blood pressu-
res, defined as variability, and the age in 17 normotensive 
subjects and between these blood pressures and the age and 
the PRA in 34 patients with benign essential hypertension. 
From the data of the hypertensive patients in these 
tables it appears that the higher the casual day-time blood 
pressures are, the higher is the lowest blood pressure at 
night. Moreover, the higher the lowest blood pressure 
values at night are, the lower is the variability. The age 
of the patients is positively correlated with the height of 
casual systolic and diastolic blood pressure and with the 
lowest systolic pressure at night. Interestingly, a loose 
though significant negative correlation was found between 
the PRA and the variability. The correlations between 
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the blood pressure and the PRA, and between the lowest 
pressure at night and the PRA are not significant. 
The casual blood pressures measured in the group of 
the normotensive control subjects are significantly positi-
vely correlated with the variability. As in the hypertensive 
patients, it appears that the higher the lowest blood 
pressure values during the night are, the lower is the 
variability. The age is not significantly correlated with 
any of the blood pressures measured in the control subjects. 
DISCUSSION 
Several authors have reported recently the usefulness 
of prolonged blood pressure recording in the assessment of 
hypertension and in estimating its variability. In this 
study a fair correlation was found between the systolic and 
the diastolic pressures measured by standard manometry and 
with the automated device Arteriosonde . In the calibration 
procedure described, a significant difference between the 
systolic pressures, obtained simultaneously by manometer 
readings taken by a physician, and Arteriosonde recording 
was not detected. Nevertheless, in the experiment in which 
a physician took blood pressures during 40 minutes in the 
room in which the subject was lying supine and in which 
the Arteriosonde recorded during another 40 minutes the 
blood pressure in the identically situated, same normoten-
sive subjects, though in the absence of the physician, the 
Arteriosonde recorded systolic and diastolic pressures were 
significantly lower than those obtained by manometry by a 
physician. This finding was irrespective of the sequence of 
both procedures. Concerning the systolic blood pressure, it 
is clear, from the calibration experiment, that the differen-
ce cannot be explained by differences between the sphygmo-
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manometer and the Arteriosonde per se. Regarding the dia-
stolic blood pressure difference, it will be remembered, 
that in the calibration the diastolic pressure with the 
conventional manometric procedure was systematically solite-
la 
what lower than with the Arteriosonde , due to a principal 
difference between both techniques. This finding is in 
agreement with those of other authors (7, 8). However, in 
the experiment under discussion, the diastolic pressure 
measured by the physician with a sphygmomanometer was sig-
li 
nificantly higher than that recorded with the Arteriosonde . 
These considerations lead to the conclusion that the 
presence of the measuring physician per se caused the higher 
systolic and diastolic readings with the conventional mano-
metric procedure as was also stated bv Irving et al (2). It 
seems important to be aware that a psychological factor, as 
detected in this experiment, should be evaluated in studies 
on the significance of depressor effects on the blood 
pressure measured. Therefore, in order to get optimal 
results in experiments centering on blood pressure beha-
viour, it seems justified to expect automated recording 
with a well calibrated device to serve such purposes better. 
In using such devices one has to realize that the blood 
pressures recorded are indeed significantly lower than with 
standard manometry. In the experiment presented in this 
study the mean blood pressures obtained by the Arteriosonde 
recording during 30 minutes were about 7 % and the lowest 
pressures during that period appeared to be about 12 % 
lower than by casual manometry, both in the normotensive 
controls as well as in a group of patients with benign 
essential hypertension. 
In the experiment in which the blood pressure was 
recorded during the night at half hour intervals, earlier 
reported similar findings were reconfirmed (1). In the 
group of hypertensive subjects studied a slightly greater 
94 
relative resistance to a decrease in the diastolic blood 
pressure during the night was observed. It is added, that 
the degree of blood pressure decrease in this experiment 
with the Arteriosonde is much more impressive than those 
reported earlier with invasive procedures (3). Furthermore, 
blood pressure variability was - though verv roughly -
approximated and evaluated to some extent. It was calculated 
that, in hypertensive patients, the variability of the 
systolic and the diastolic blood pressure does not signifi-
cantly change with increasing age, whereas the absolute 
systolic and diastolic casual day-time, as well as the 
recorded lowest systolic blood pressure with the Arterio-
le 
sonde during the night increased the older the patient grew. 
The correlation between the casual day-time and the night-
time lowest pressures - systolic and diastolic - was of the 
same order of tightness as found in the experiment in which 
short-term Arteriosonde recorded blood pressures were 
compared with casual manometric readings. Remarkably, in the 
smaller group of normotensive control subjects - in contrast 
with the hypertensive population - these correlations 
appeared to be not significant. A significant difference in 
the variances of the mean values between these groups did 
not exist. The lowest night-time blood pressures were signi-
ficantly negatively correlated with the variability in both 
the hypertensive patients and the normotensive subjects. 
However, the casual day-time pressures appeared to be sig-
nificantly and positively correlated with the variability 
in the normotensive subjects, not significantly however in 
the hypertensive patients. A significant difference in the 
standard deviation of the respective values of the variabi-
lity of the blood pressure, as defined in this study, was 
not detectable. These considerations taken together, the 
conclusion seems inevitable that the casual systolic and 
diastolic day-time blood pressure levels in normotensive 
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subjects are per se much more varying qualities than those 
in hypertensive patients. 
The interesting observation that the variability of 
both the systolic and the diastolic blood pressure was -
though loosely - significantly and negatively correlated 
with the renin state of the hypertensive patient deserves 
some comment. There is an current discussion and dispute in 
the literature about the meaning of the concept 'low renin' 
hypertension. In this laboratory by 'low renin' hypertension 
is meant a hypertensive disorder with a renin activity, 
measured after stimulation by sodium restriction for 5 days 
and 3 h of ambulation lower than in normotensive controls. 
In earlier studies in this laboratory it has been shown 
that a classification according to that procedure differs 
from a classification based upon renin measurement without 
rigid sodium restriction (9) or based upon renin measure-
ments after stimulation with furosemide (10). The negative 
correlation found between the variability of the blood 
pressure and the in this way determined renin state in 
hypertensive patients means, that a greater variability of 
pressure concurs with a lower plasma renin activity. This 
provocative statement necessitates additional studies. 
Finally, in this limited number of hypertensive patients 
the negative correlation between plasma renin activity 
and the age of the patient was not found to be significant, 
in contrast with the results of other investigators (11 -
13) and the observations in a larger series of patients in 
this laboratorv as well (14). 
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ABSTRACT 
In this study the blood pressure lowering effects of 
long-term treatment with the diuretic chlorthalidone, the 
anti-aldosterone drug spironolactone and the ß-blocker 
propranolol have been compared in the same patients. 
Besides the effect of the drugs on blood pressure, plasma 
renin activity and plasma aldosterone, attention has been 
paid to changes in body weight, plasma electrolyte concen-
trations and glomerular filtration rate. All patients had 
mild essential hypertension with normal plasma renin 
activity. 
All three drugs decreased the blood pressure signifi-
cantly and none of the agents was superior in their blood 
pressure lowering effect. The blood pressure did not norma-
lize. The data suggest that neither volume factors, 
relative hyperactivity of the renin-aldosterone system nor 
¡3-adrenergic hyperactivity is the prime mover in normore-
ninemic hypertension. Long-term chlorthalidone treatment 
resulted in slight hyperreninism with concomitant changes 
in plasma aldosterone. The body weight decreased signifi-
cantly. The concentrations of sodium, potassium and chlori-
de in plasma decreased. The creatinine clearance was 
unimpaired. Chronic treatment with spironolactone resulted 
in more marked hyperreninism and high plasma aldosterone 
concentrations were found. The body weight decreased 
significantly. The concentrations of plasma sodium and 
chloride were lower than without treatment and a significant 
hyperkalemia occurred. The glomerular filtration rate 
decreased. Long-term propranolol treatment resulted in 
marked suppression of the plasma renin activity and plasma 
aldosterone levels. The body weight increased significantly. 
The concentrations of plasma sodium and chloride decreased 
significantly and a slight though significant hyperkalemia 
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occurred.The glomerular filtration rate decreased. 
Hyperreninemia (by spironolactone and chlorthalidone), 
effective hyperaldosteronism (by chlorthalidone) and volume 
retention (by propranolol) are considered to represent 
expressions of mechanisms counteracting the depressor 
effects of these different pharmacological maneuvers, 
leading to the maintenance of a supranormal blood pressure. 
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INTRODUCTION 
There is good evidence that lowering mild elevated 
blood pressures prevents later rises (1 - 4). In recent 
years the use of diuretics and ß-blockade has increased 
considerably to that purpose. 
Comparison of the effectiveness of diuretics and 
ß-blockade in the same hypertensive patients is the subject 
of this study. In order to exclude bias of the results by 
including 'low renin' or 'high renin' patients, normoreni-
nemics have been deliberately chosen. To relate the 
depressor effect of diuretics and R-blockade to the activity 
of the renin-angiotensin-aldosterone system during treatment 
more delicately, the thiazide-type diuretic agent chlortha-
lidone and the anti-aldosterone agent spironolactone have 
been included in the comparison with ß-blockade by propra-
nolol. Besides the activity of the renin-angiotensin-
aldosterone system and the depressor effect, changes in 
body weight, glomerular filtration rate and plasma electro-
lytes have been given attention. 
Surprisingly, similar though not normalizing blood 
pressure lowering by these three principally pharmacologi-
cally different agents was observed in the presence of 
marked differences in a number of seemingly related 
variables. 
METHODS 
Patients with mild hypertension were selected at 
random from the outpatient clinic. Their diastolic blood 
pressure measured, off treatment, by auscultation, after 
ten minutes of recumbency was higher than 95 mmHg. Secondary 
causes of hypertension, such as pheochromocytoma, Cushing's 
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Syndrome, renal artery stenosis and primary aldosteronism 
were exluded by appropriate laboratory and roentgenogra-
p h ^ procedures. The plasma renin activity (PRA) was 
measured after 5 days of controlled sodium restriction as 
well as after 5 days of chlorthalidone treatment. After both 
regimens blood for PRA was taken at noon after 3 h of ambu-
lation. With both procedures patients with low and normal 
PRA can be discriminated (5). Eleven patients, 5 female and 
6 male, with a PRA in the range of normotensive controls 
were studied. Their age ranged from 32 to 59 (mean age 44 
years). Cardiac and renal function were unimpaired in all 
of them. After giving their informed consent the patients 
were treated according to the protocol as depicted in Fig. 1. 
.^two
 > 
' weeks! 
chlorthalidone 
100 mg per day 
placebo sodium 
load 
Hosp. spironolac-
tone 
400 mg per 
day 
placebo propranolol 
160-320 
480-640 mg per day 
î î Î î î Î î Î î Î ΐ î Î 
unrestricted diet unrestricted diet 
I : det ermination of : blood pressure 
body weight 
plasma electrolytes 
serum creatinine 
î additional determination of: 
plasma renin activity 
plasma aldosterone 
urinary creatinine excretion 
t Hospitalization 
Fig. 1. Study design. 
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The patients were subsequently treated with chlorthalidone, 
100 mg per day for at least 6 weeks, spironolactone, 400 mg 
per day during 4 weeks and propranolol during 8 weeks in 
increasing doses up to 640 mg per day in 9 patients, and 
320 mg per day in two patients. The highest doses of pro-
pranolol were administered for at least 5 weeks. During the 
study period the patients were seen at 2 week intervals. 
Each visit the blood pressures were recorded between 8 and 
10 a.m. with an automated device (Arteriosonde ) every 5 
minutes during 40 minutes of recumbency. The average of the 
pressures recorded during the last 30 minutes was considered 
as the representative blood pressure of the visit. The 
patients were weighed and blood was taken for the measure-
ments of the concentrations of sodium, potassium and 
chloride in plasma and for the measurement of the creatinine 
concentration in serum. At the end of each treatment period 
the PRA and the concentration of plasma aldosterone were 
measured in blood taken after 3 h of ambulation at noon and 
the creatinine excretion was measured in urine collected 
during the preceeding 12 hours. 
The treatment periods were separated by a placebo 
phase. In the 5th week of the first placebo phase the basal 
measurements of the blood pressure, electrolyte concentra-
tions in plasma and creatinine concentration in serum were 
done. In the 6th week of this period the patients consumed 
an extra sodium load (9 grams of NaCl extra per day) for 5 
days, on the last day of which the same measurements were 
performed as at the end of each treatment schedule. A short 
clinical observation followed, during which the PRA was 
measured after 5 days of controlled sodium restriction (15 
mEq of sodium per day) and 3 h of ambulation at noon and the 
aldosterone secretory rate was measured on the 6th day of 
sodium restriction during 24 h of recumbency. The potassium 
intake during hospitalization ranged from 50 - 90 mEq per 
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day. The creatinine clearance was measured repeatedly during 
hospitalization. After the fourth week of the second placebo 
period the same observations were done as in the fifth week 
of the first placebo period. In the intervals between 
measurements each subject carried on a normal out-patient 
life without restriction of dietary sodium intake. The sodium, 
potassium and chloride concentrations in plasma and the cre-
atinine concentration in serum and urine were measured by 
standard laboratory procedures. The PRA was measured by 
radioimmunoassay. The PRA measured in 22 normotensive control 
subjects (17 - 55 yr) after 3 h of ambulation at noon 
without any dietary regimen was 4.6 + 0.5 ng.ml :.3 h ' (6). 
PRA values measured after clinical sodium restriction for 5 
days and 3 h of ambulation at noon being higher than 11.5 
ng.ml '.3 h l were considered as normal in our laboratory 
(5). The PRA measured after 5 days of chlorthalidone treat-
ment in an in age comparable group of 11 (5 female and 6 
male) normotensive control subjects was 40.7 + 5.6 ng.ml '. 
3 h 1 . The plasma aldosterone concentration and the aldo-
sterone secretory rate were measured by radioimmunoassay. 
The aldosterone secretory rate during sodium restriction 
measured in an in age matched group of normotensive control 
subjects was 415 + 49 y/24h. Non-parametric statistical 
methods were used to detect differences between paired 
observations (Wilcoxon's test). The results are expressed 
as means + SE. 
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RESULTS 
Observations during the placebo periods. 
The blood pressures recorded automatically by the 
Arteriosonde in these patients in the first placebo period 
were compared with those measured in an in age and sex 
ratio comparable group of normotensive control subjects. 
The systolic and the diastolic blood pressure- as well as 
the calculated mean arterial pressure in the former group 
was significantly higher than the respective blood pressures 
recorded in the same way in the latter group (Table 1). 
Table 1. COMPARISON OF SYSTOLIC (P SYST) AND DIASTOLIC 
(P DIAST) BLOOD PRESSURE AND THE CALCULATED MEAN ARTERIAL 
PRESSURE (MAP) I NORMOTENSIVE CONTROL SUBJECTS AND HYPER­
TENSIVE PATIENTS. THE DATA IN THE FORMER GROUP WERE 
OBTAINED IN A WAY IDENTICAL TO THAT DESCRIBED FOR THE LATTER 
IN THE METHODS SECTION. 
Ρ syst 
Ρ diast 
MAP 
mmHg 
NORMOTENSIVE 
CONTROL SUBJECTS 
η = 11 
111 + 2 
72 + 2 
85 + 2 
< 
< 
< 
Ρ 
.001 
.001 
.001 
HYPERTENSIVE 
PATIENTS 
η = 11 
152 + 5 
99 + 2 
116 + 2 
Compared to the measurements done in normotensive 
control subjects, the 11 hypertensive patients had a normal 
PRA after sodium restriction ranging from 12.6 to 38.1 
106 
ng.ml_1.3 h"1 (mean 20.9 + 2.7 ng.ml_1.3 h " 1 ) . After 5 days 
of chlorthalidone treatment the mean PRA was not signifi­
cantly different from the mean found in an in age and sex 
ratio comparable group of normotensive control subjects 
(48.0 + 6.2 and 40.7 + 5.6 ng.ml *.3 h ' respectively, ns). 
The aldosterone secretory rate measured after sodium re­
striction was significantly lower than the value found in 
age matched normotensive control subjects (265 + 40 and 
415 + 49 γ/24η respectively, ρ < 0.01). Sodium loading with 
9 grams of sodium chloride per day in addition to the unre­
stricted diet resulted in a suppression of the PRA to 3.0 + 
0.6 ng.ml !.3 h 1 whereas the plasma aldosterone concentra­
tion at the same time was 6.7 + 1.3 pg/100 ml. The creati­
nine clearance measured after sodium loading was not signi­
ficantly different from the mean creatinine clearance 
measured during hospitalization (117 + 5 and 120 + 5 ml/min 
respectively, ns). Sodium loading did not result in a sig­
nificant rise in body weight in these patients (69.5 +2.6 
before and 69.7 + 2.6 kg at the end of 5 days of sodium 
loading) and symptoms nor signs of heart failure were found. 
To study the effect of the different anti-hypertensive 
agents, the observations done in the fifth week of the 
first placebo period were compared to those obtained at the 
end of each treatment schedule. The results obtained in the 
first placebo period did not differ significantly from 
those obtained at the end of the second placebo period. 
Observations during treatment. 
Dut-£atient observâtions_after_chlorthalidone treatment. 
The results of anti-hypertensive treatment with 
chlorthalidone therapy for 6 weeks (100 mg per day) were 
compared with the results measured in the fifth week of the 
:irst placebo period (Table 2). 
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Table 2. COMPARISON OF CLINICAL AND BIOCHEMICAL VARIABLES 
MEASURED AFTER LONG-TERM CHLORTHALIDONE TREATMENT WITH 
THOSE MEASURED AFTER THE PLACEBO PERIOD. 
P syst 
Ρ diast 
MAP 
mmHg 
BODY WEIGHT 
KG 
PLASMA SODIUM 
PLASMA POTASSIUM 
PLASMA CHLORIDE 
mEq. 1 ~ ' 
SERUM CREATININE 
umol.1 
CREATININE CLEARANCE 
ml.min 
PLACEBO 
152 
99 
116 
69. 
143 
3. 
107 
87 
120 
5 
9 
+ 5 
+ 2 
+ 2 
І
 2
·6 
• 1 
• 0.1 
+ 1 
t 6 
i 5* 
Ρ 
< .005 
< .032 
< .006 
< .005 
< .029 
< .004 
' .003 
η. s. 
η. s. 
CHLORTHALIDONE 
130 
93 
105 
67. 
141 
3. 
99 
86 
117 
7 
2 
i 4 
+ 3 
+ 3 
+ 2.0 
+ 1 
+ 0.1 
+ 1 
+ 6 
І 6 
χ measured during hospitalization 
η.s.: not significant. 
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The systolic and the diastolic blood pressure, measured 
with the Arteriosonde and the calculated mean arterial 
pressure decreased significantly. The mean body weight was 
significantly lower, 1.8 kg, than in the placebo period. 
The concentrations of sodium, potassium and chloride 
decreased significantly. The serum creatinine concentration 
measured after long-term chlorthalidone treatment did not 
differ significantly from the value found in the placebo 
phase. The creatinine clearance calculated was not signifi-
cantly different from the mean creatinine clearance 
measured during hospitalization or after sodium loading. 
Out-£atient observations_after_s£ironolactone treatment. 
The results of anti-hypertensive treatment with spiro-
nolactone therapy for 4 weeks (4 00 mg per day) were compared 
with the results measured in the placebo period (table 3). 
The systolic and diastolic blood pressure recorded and 
the calculated mean arterial pressure decreased significantly 
during spironolactone treatment. The mean body weight 
measured after spironolactone was significantly lower, 1.9 
kg, than in the placebo period. The concentrations of sodium 
and chloride decreased significantly and the plasma potassium 
concentration increased significantly. The serum creatinine 
concentration measured after chronic spironolactone treatment 
was significantly higher than the value found in the placebo 
period. Accordingly, the creatinine clearance calculated 
after spironolactone was significantly lower than the mean 
creatinine clearance measured during hospitalization or after 
sodium loading. 
Out-p_a tient observa tions_after_prop_r ano lo l_t£eatment_:_ 
The results of antihypertensive treatment with 
propranolol treatment for 8 weeks (up to 640 and 320 mg per 
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Table 3. COMPARISON OF CLINICAL AND BIOCHEMICAL VARIABLES 
MEASURED AFTER LONG-TERM SPIRONOLACTONE TREATMENT WITH 
THOSE MEASURED AFTER THE PLACEBO PERIOD. 
Ρ syst 
Ρ diaet 
MAP 
mmHg 
PLACE 
152 
99 
116 
ВО 
+ 5 
+ 2 
+ 2 
Ρ 
<.003 
<.046 
<.007 
SPIRONOLACTONE 
132 
94 
106 
+ 5 
+ 2 
+ 3 
BODY WEIGHT 
KG 
69.5 + 2.6 67.6 + 2.2 
PLASMA SODIUM 
PLASMA POTASSIUM 
PLASMA CHLORIDE 
mEq. 1 
SERUM CREATININE 
μιηοΐ. 1 
CREATININE CLEARANCE 
ml.min 
143 
3.9 
107 
87 
120 
+ 
+ 
+ 
+ 
+ 
1 
0.1 
1 
6 
5' 
<.ooa 
< .014 
<.004 
< .014 
<.004 
139 
4.4 
102 
99 
93 
+ 1 
+ 0.1 
+ 1 
+ 5 
+ 3 
ж measured during hospitalization 
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T a b l e 4 . COMPARISON OF CLINICAL AND BIOCHEMICAL VARIABLES 
MEASURED AFTER LONG-TERM PROPRANOLOL TREATMENT WITH THOSE 
MEASURED AFTER THE PLACEBO PERIOD. 
P syst 
Ρ dlast 
MAP 
mmHg 
BODY WEIGHT 
KG 
PLASMA SODIUM 
PLASMA POTASSIUM 
PLASMA CHLORIDE 
mEq.l" 1 
SERUM CREATININE 
umol.1 
CREATININE CLEARANCE 
PLACEBO 
152 
99 
116 
69. 
143 
3. 
107 
67 
120 
5 
9 
* 5 
+ 2 
+ 2 
+ 2.6 
+ 1 
+ 0.1 
+ 1 
І 6 
i 5* 
Ρ 
<.006 
< . 019 
< .003 
< . 013 
< . 017 
< .049 
< .036 
<.039 
<.00θ 
PROPRANOLOL 
133 
90 
105 
71.θ 
140 
4.2 
104 
94 
99 
+ 5 
+ 3 
І 4 
+ 2.3 
+ 1 
+ 0.1 
• 1 
+ 6 
+ 5 
* measured during hospitalization 
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day, at least during the last 5 weeks) were also compared 
with the observations done in the first placebo period 
(table 4). Propranolol treatment caused a significant 
decrease in the systolic, the diastolic and the mean 
arterial pressure. The mean body weight however increased 
significantly during propranolol treatment, 2.3 kg. The 
concentrations of sodium and chloride decreased significantly 
during propranolol medication, the plasma potassium concen-
tration however was significantly higher after propranolol. 
The serum creatinine concentration measured after long-term 
propranolol treatment was significantly higher than the 
value found in the placebo period. The creatinine clearance 
after propranolol was significantly lower than the mean 
creatinine clearance measured during hospitalization or 
after sodium loading. 
Compar_ison_of_ the £e£urts_ after chlorthalidone_¿_ s_Pir£n°la.cZ 
tone_or £ropranolol. 
The results of treatment of the same patients with 
either the thiazide-type diuretic chlorthalidone, or the 
aldosterone-antagonist spironolactone, or the ß-blocking 
agent propranolol are compared in table 5. 
The blood pressure levels reached with each drug 
appeared to be equal. The small differences found between 
the mean systolic blood pressures measured after the three 
treatment schedules were not significant, neither were the 
differences found between the mean diastolic pressures nor 
between the calculated mean arterial pressures. 
The mean body weight measured at the end of propranolol 
treatment was significantly higher than the body weights 
measured after chlorthalidone or spironolactone. The mean 
body weight measured after chlorthalidone was not signifi-
cantly different from that after the latter. 
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T a b l e 5 . COMPARISON OF THE EFFECTS OF LONG-TERM ANTIHYPER­
TENSIVE TREATMENT WITH CHLORTHALIDONE, SPIRONOLACTONE AND 
PROPRANOLOL IN ELEVEN PATIENTS WITH NORMORENINEMIC 
ESSENTIAL HYPERTENSION. 
CHLORTHALIDONE SPIRONOLACTONE PROPRANOLOL 
Ρ Ρ 
Ρ syst 130 + 4 n.s. 132 + 5 η.s. 133 + 5 
Ρ diaet 93 + 3 η.β. 9 4 + 2 η.s. 90 + 3 
MAP 105 + 3 η.s. 106 + 3 п.з. 105 + 4 
mmHg 
BODY 
WEIGHT 67.7 + 2.0 п.в. 67.6 + 2.2 <.0Ο6 71.θ + 2.3 
KG 
PLASMA 
SODIUM 141 + 1 <.044 139 + 1 η.s. 140 + 1 
PLASMA 
POTASSIUM 3.2 + 0.1 <.004 4.4 + 0.1 n.s. 4.2 + 0.1 
PLASMA 
CHLORIDE 99 + 1 <.004 102 + 1 п.ч. 104 + 1 
mEq.l - 1 
SERUM 
CREATININE Θ6 + 6 < . 0 0 S 9 9 + 5 n . s . 94 + 6 
иmo1.1 
CREATININE 
CLEARANCE 117 + 6 < . 0 0 5 9 3 + 3 n . s . 99 + 6 
m l . m i n " 
PLASMA RENIN 
ACTIVITY 2 6 . 3 + 4 . 9 n . s . 4 7 . 0 + 1 4 . 3 < . 0 0 6 1.8 + 0 . 2 
PLASMA 
ALDOSTERONE 2 3 . 0 + 3 . 2 < . 0 0 1 6 1 . 9 + 1 1 . 
p g . 1 0 0 m l " 1 
• ρ values versus chlorthalidone 
n.s.: not significant. 
n.s. 
n.s. 
n.s. 
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A small though significant difference was found between 
the concentrations of sodium in plasma after chlorthalidone 
and spironolactone. The lower plasma sodium concentration 
was measured after spironolactone. The mean sodium concen-
tration after propranolol was in between those after chlor-
thalidone and spironolactone and did not differ significant-
ly from both. The mean plasma potassium concentration after 
chlorthalidone was significantly lower than the mean plasma 
potassium concentration after spironolactone or propranolol. 
The mean plasma potassium concentration measured after 
spironolactone was not significantlv different from the 
mean plasma potassium concentration after propranolol. The 
concentrations of chloride in plasma were about equal after 
spironolactone and propranolol, but both significantly 
higher than the plasma chloride concentration measured 
after chlorthalidone treatment. The creatinine concentra-
tion in serum and the calculated creatinine clearance were 
about the same after both spironolactone and propranolol 
treatment. The serum creatinine concentration measured 
after chlorthalidone however was significantly lower and 
the creatinine clearance significantly higher than after 
spironolactone or propranolol. The PRA after 4 weeks of 
spironolactone was higher than after chlorthalidone. 
However, this difference appeared to be not significant due 
to the large spread of values measured after 4 weeks of 
spironolactone. The PRA-values measured after propranolol 
were extremely low. The plasma aldosterone concentration 
measured after chronic chlorthalidone treatment was signi-
ficantly lower than the plasma aldosterone concentration 
after long-term spironolactone but both were significantly 
higher than the plasma aldosterone concentration measured 
after propranolol. 
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DISCUSSION 
The antihypertensive potential of diuretics, both of 
the thiazide-type as well as of the anti-aldosterone-type, 
and of ß-adrenergic blocking drugs have been reported in 
numerous studies. However, to the best of our knowledge no 
study has been published in which the antihypertensive 
effects of the diuretics chlorthalidone and spironolactone, 
and the effect of the ß-blocker propranolol have been com-
pared in the same hypertensive individuals. Normoreninemic 
patients have been chosen deliberately to exclude bias of 
the results by studying patients of possible subgroups of 
hypertensives such as the 'low-renin' hypertensives which 
according to some investigators might hyperreact to an 
anti-aldosterone agent (7, 8, 9) or the 'high-renin' hyper-
tensive patients according to others probably more sensi-
tive to the depressor effect of ß-blocking drugs (10). The 
patients studies were, according to clinical criteria, of 
the benign essential hypertension type and did secrete 
amounts of aldosterone, after rigid sodium restriction, 
even lower than in normotensive controls. 
By using the non-parametric Wilcoxon's test for paired 
observations the significant decrease of the mean blood 
pressure by each of the drug schedules can be considered to 
be representative for each patient and therefore the 
probability is exceedingly low that excessive depressor 
effects in individual patients might be responsible for the 
observed depressor effects of these drugs. Indeed, the data 
of the blood pressure changes in each individual patient 
were in accordance with this thesis. 
Remarkably, the mean decrease of the blood pressure 
level (systolic, diastolic and mean arterial pressure) with 
either of these three drugs was about equal. Furthermore, 
none of these three drugs given in fairly high doses 
H5 
normalized the mean blood pressure in this sample of mild 
hypertensives. This equal though not normalizing,decrease 
of the blood pressure by these three drugs suggests that 
volume factors neither hyperactivity of the hormonal renin-
angiotensin-aldosterone svstem nor the R-adrenergic system 
play the predominant role in the etiology of normoreninemic 
benign hypertension. 
Interestinglv, б weeks of chlorthalidone and 4 weeks 
of spironolactone treatment decreased bodv weight almost 
identically. On the contrary, propranolol treatment induced 
a significant weight gain. In two of the 11 patients of 
this study clinically detectable ankle edema was observed. 
By virtue of the same statistical arguments as given above, 
it is highly improbable that these weight decreases and 
increases have been caused by excessive weight changes in 
some individuals. Obvious changes in caloric intake have 
not been admitted by these patients during either treatment. 
Therefore it is considered that the weight changes represent 
changes in extracellular fluid volume. In fact Sederberg-
Olsen (11) et al found a significant rise in extracellular 
fluid volume during long-term treatment with propranolol. 
Taken this into account, an almost identical blood pressure 
lowering occurred in this group of normoreninemic hyperten­
sives both in the presence of volume depletion either by 
chlorthalidone or spironolactone as well as in the presence 
of supposed volume surfeit by propranolol. 
Most authors agreed that the depressor activity of 
diuretics is initiated by hypovolemia. Concerning their 
chronic antihypertensive effect other hemodynamic adjust­
ments have not been excluded (12). Hypovolemia was measured 
to exist even after treatment for several weeks or months 
(13 - 15). Indirect evidence for persisting hypovolemia has 
been given by Vaughan et al (16) who found sustained 
elevations of plasma renin activity and aldosterone excretion 
116 
during long-term treatment with either chlorthalidone or 
spironolactone. The depressor activity of propranolol was 
accompanied by signs and symptoms of decreased cardiac 
performance; the pulse rate decreased significantly (from 
7 9 + 2 per minute before to 64 + 3 after propranolol) in 
the presence of blood pressure lowering and clinical sings 
of volume retention - increase in body weight and ankle 
edema in some of the patients - occurred. It is added that 
in this group of patients latent cardiac failure was not 
present as was proven by the lack of volume retention 
during sodium loading with extra NaCl for 5 days. In a 
number of studies it has indeed been indicated that 
ß-blockade depresses the cardiac index (17, 18). It is 
amply known that decrease of cardiac performance leads to 
sodium and water retention by the kidneys (19, 20) and 
ensuing weight gain. Several investigators, however, did not 
observe signs and svmptoms of volume retention during 
ß-blockade in patients without cardiac failure (17, 21). 
In addition to the decrease in cardiac performance, 
ß-blockade appeared to suppress the action of the renin-
angiotensin-aldosterone system, as was earlier reported by 
other investigators (10, 18, 21, 22). In this study the 
renin and aldosterone levels after propranolol were as low 
as those measured after sodium loading. This suppression 
might contribute to the blood pressure lowering effect of 
ß-blockade. However, other ß-hlocking drugs have been 
reported to decrease the blood pressure in the absence of 
a discernable decrease in plasma renin activity (23, 24). 
Therefore one might indeed doubt if the direct action of 
ß-blockade on renin release and the consequently occurring 
hypoaldosteronism were the main factor causing a decrease 
in blood pressure. From the overall evidences of this 
study the decrease in cardiac performance is considered to 
be the more important factor in blood pressure control in 
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this group of patients. It should be mentioned however, that 
central nervous system actions of this pharmacological 
maneuver cannot be excluded to contribute to the blood 
pressure lowering effect of ß-blockade. 
By comparing the effects observed during chlorthalidone, 
spironolactone and propranolol treatment it is interesting 
to delineate the changes in the activity of the renin-
angiotensin-aldosterone system and those in plasma electro-
lytes and renal function. In the presence of almost identical 
weight decreases by volume depletion and indistinguishable 
depressor actions of chlorthalidone and spironolactone, the 
plasma aldosterone levels after the latter appeared to be 
significantly higher than after the former, whereas the 
plasma renin activities were not significantly different. 
It is quite conceivable that the significantly higher plasma 
potassium concentration after spironolactone treatment was 
responsible for this difference between the plasma aldoste-
rone levels. In favor of this explanation a significant 
positive correlation between plasma potassium and plasma 
aldosterone levels was calculated during spironolactone 
treatment (Spearman's rank-correlation test; r = 0.66, 
η = 11, ρ < 0.05). Still in another aspect the thiazide-
type of diuretic action differed from the anti-aldosterone 
treatment. After both diuretic schedules the mean plasma 
sodium concentration decreased, however the mean concentra­
tion of sodium after spironolactone was significantly lower 
than after chlorthalidone. Accordingly, plasma chloride 
levels after both treatment decreased, however after spiro­
nolactone the mean chloride level was significantly higher 
than after chlorthalidone. As mentioned already, a signifi­
cant hypokalaemia persisted after 6 weeks of chlorthalidone 
whereas the mean potassium concentration after 4 weeks of 
spironolactone was significantly higher than in the placebo 
period. These differences in the effects of chlorthalidone 
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and spironolactone on plasma sodium, chloride and potassium 
concentrations could be expected from the main anti-aldoste-
rone effect of spironolactone and the pure natriuretic, 
chloruretic and consequent - due to secondary aldosteronism -
kaliuretic effect, of chlorthalidone. Concerning the changes 
in the concentrations of these plasma electrolytes after 
chronic ß-blockade, it is remembered that the plasma sodium 
and chloride concentrations were significantly lower and the 
plasma potassium concentration significantly higher 
than in the placebo period. These changes after propranolol 
treatment were comparable and not significantly different 
from the corresponding changes after spironolactone. It is 
therefore tempting to speculate that the observed suppressed 
activity of the renin-angiotensin-aldosterone system was 
responsible for these propranolol induced electrolyte changes 
as was the anti-aldosterone action in case of spironolactone. 
After both spironolactone and propranolol treatment the 
calculated creatinine clearance was significantly lower than 
after chlorthalidone. After the latter the creatinine 
clearance did not differ significantly from that in the 
placebo period. The decrease of the glomerular filtration 
rate after propranolol is in accordance with an earlier 
report by Ibsen et al (26) and these authors stated that this 
change could be due to the decrease in cardiac performance. 
Concerning the decrease of the glomerular filtration rate 
after spironolactone one might wonder if the anti-aldosterone 
activity of the drug were responsible for this effect. 
Indeed, it is well known that in clinical situations of 
hypoaldosteronism, e.g. in adrenal insufficiency, or in 
patients with isolated hypoaldosteronism decreased glomerular 
filtration rate is not uncommon (26 - 28). It remains to be 
explained why after chronic chlorthalidone treatment, in the 
presence of volume depletion, the creatinine clearance does 
not differ from that in the control period. 
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SUMMARY 
The activity of the renin-angiotensin system is 
considered to represent a marker of a complex of factors 
that can cooperate in the pathogenesis of hypertension and 
that might have prognostic significance with regard to its 
natural course and to the effect of differing modes of treat-
ment. In extreme situations, e.g. advanced or malignant 
hypertension and primarv mineralocorticoidism, the renin 
activity in most cases is extremely high or low. In recent 
years a discussion has been going on in the literature with 
regard to the significance of the classification of hyper-
tensive patients in low, normal and high renin individuals. 
A classification of this kind requires a careful definition 
of what is normal. 
It is well known that the plasma renin activity in 
normotensive controls varies widely from subject to subject 
even under rigidly controlled conditions in a metabolic 
ward. Besides, intra-indlvidually the renin activity shows 
spikes and nadirs not yet understood. In this context it 
seems unnecessary to comment that standardization of 
methods to measure renin is urgently needed. Furthermore, 
attention should be paid to the way in which the renin 
status of a hypertensive individual can be screened reliably 
even on an out-patient base. In this thesis some aspects of 
the renin-angiotensin system in essential hypertension are 
presented. 
In chapter I, the reliability of the measurement of 
plasma renin activity by radioimmunoassay is described. The 
incubation and elution procedures used in this radioimmuno-
assay were the same as those in the formerly used bioassay. 
The amount of angiotensin I generated during the first 
three hours of incubation appeared to be linear with time. 
Only a negligible amount of angiotensin I was found in non-
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incubated plasma samples as well as in plasma samples 
incubated for 3 hours at 4° C. Measurable amounts of angio-
tensin I could not be detected in plasma samples from 
nephrectomized patients with this radioimmunoassay procedu-
re. The interassay variation was about 13 %. The recovery 
of the assay was 89 %. The lowest measurable amount of 
angiotensin I in the incubation mixture was 5 pg. From this 
value the lowest detectable PRA value was calculated to be 
0.5 ng.rnl"1.3 h~'. 
The specificity of the method was illustrated by the 
comparison of the assay results with those of the formerly 
used bioassay. Using the same incubation and extraction pro-
cedures a highly significant positive correlation was found 
between the results of both methods. The radioimmunoassay 
values were 2.4 + 0.6 times higher than the bioassay results. 
This difference between the results of both assays was to be 
expected because of the different standards of angiotensin 
used. In the radioimmunoassay angiotensin I and in the bio-
assay angiotensin II was used as the standard. 
To arrive at a better understanding of the widely 
differing ranges of renin activities reported to occur in 
normotensive control subjects, two observations in this 
study seem important. First, the response differences found 
between the antibody and the different angiotensin I stan-
dards tested and secondly, the difference found between the 
results of two radioimmunoassay techniques, one with and one 
without extraction of angiotensin I from the incubation 
mixture. To enable comparison of assay results in different 
laboratories it seems important to express the plasma renin 
activities in terms of an international standard renin. The 
radioimmunoassay used in this laboratory was calibrated to an 
internationally accepted standard renin and after recalcu-
lation of the results obtained in normotensive control 
subjects the range of values was in much better agreement 
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with those reported by other laboratories using the same 
standardization. 
In Chapter II results of the measurement of plasma 
renin activity after different renin stimulating maneuvers 
are described. In the introduction section of this chapter 
it is emphasized that the wide range in the reported 
frequency of so called 'low renin' hypertension can be 
partly due to the widely varying renin stimulating maneuvers 
used. The measurement of the plasma renin activity after 5 
days of rigidly controlled sodium restriction in hospital 
and 3 h of ambulation has been considered to be the 
preferred method in a number of studies. With this sodium 
restriction test as the reference method, two out-patient 
renin stimulating methods have been compared with regard to 
their discriminating capacity to classify hypertensive 
patients as low- or normal renin patients. The use of furo-
semide (140 mg, orally in 3 doses in 18 h) in out-patients 
did not result in the detection of the same low renin 
hypertensives as the sodium restriction test. The interper-
sonal variability in the réponse to high doses of furose-
mide given in a very short time was thought to account for 
this discrepancy. When chlorthalidone was given (100 mg per 
day for 5 days) to out-patients, however, the same patients 
were detected to be of the low renin type of hypertension 
as those selected with the in-patient sodium restriction 
test. Moreover, a highly significant positive correlation 
was calculated between the results of both tests. 
In the first part of Chapter III additional data are 
given about the comparison of both tests. The renin values 
found after chlorthalidone and those found after sodium 
restriction in normotensive control subjects are reported. 
Only two patients with borderline renin values after sodium-
restriction were misclassified. The correlation between the 
results of both tests in these 60 patients was highly 
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significantly positive (r = 0.77, ρ < 0.001). 
In the second part of Chapter III the results of the 
classification with the chlorthalidone test are compared 
with those after different levels of sodium intake. From 
these data it is clear that by renin measurements without 
stimulation of renin secretion a radically different classi­
fication in lower and higher renin levels would be obtained 
than with the chlorthalidone test. Moreover, most renin 
values measured in the hypertensive patients after moderate, 
unrestricted or high sodium intake were within the range 
found in normotensive control subjects on unrestricted 
sodium intake. 
The data in Chapters II and III clearly illustrate 
that, in order to be able to classify on an out-patient base 
the same group of patients as hypo- or normoreninemics as 
with the sodium restriction procedure in hospital. The 
different results obtained by tests in which renin secretion 
was not stimulated, or stimulated with considerable inter­
personal variation with reference to the sodium restriction 
procedure might explain, to some extent, the current dispute 
about etiology, effectiveness of pharmacologically different 
antihypertensive drugs and prognosis in low renin and normal 
renin hypertension. 
With the tools described in the previous chapters of 
this thesis, patients with low and normal renin activity 
were selected from the out-patient clinic to cooperate in a 
study covering the effectiveness of different therapeutic 
approaches in relationship to their renin state. Special 
attention has been given to the measurement of the blood 
pressure in this study. 
The automated device and its usefulness in the blood 
pressure recording is described in Chapter IV. From the 
first part of the studv it appeared that the blood pressure 
levels measured simultaneously by auscultation and by 
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automatic recording did not differ significantly. Further-
more, blood pressure measurements bv auscultation (with a 
physician in the room of the patient) and by automated re-
cording (in the absence of the physician) during successive 
periods of 40 minutes were compared. With the former method 
significantly higher blood pressures were obtained than 
with the latter. Compared with casual blood pressure 
readings significantly lower blood pressures were obtained 
during 30 minutes of automatic recording at day-time. Both 
in normotensive control subjects and in hypertensive 
patients the mean of the systolic and diastolic blood 
pressure was about 7 % and the lowest value about 12 % 
below the casual reading. During the night a more pronounced 
blood pressure decrease was observed. In normotensive con-
trol subjects and hypertensive patients the lowest systolic 
pressure recorded during the night was about 32 % lower 
than the casual systolic blood pressure. With regard to the 
diastolic blood pressure, the relative difference between 
the casual reading and the lowest diastolic blood pressure 
recorded during the night was 35 % in normotensive control 
subjects and 26 % in hypertensive patients (p < 0.003). 
The absolute difference between the casual blood 
pressure measured at day-time and the lowest blood pressure 
recorded during the night was defined as the variability of 
the blood pressure. The height of the variability was not 
related to age either in hypertensive patients or in normo-
tensive control subjects. In the hypertensive patients a 
significant negative correlation was calculated between the 
variability and the plasma renin activity. The height of 
the day-time or night-time blood pressure was not signifi-
cantly correlated with the height of the plasma renin 
activity. From the correlation coefficients calculated 
between the casual blood pressure, the lowest blood pressure 
during the night and the variability in normotensive control 
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subjects and hypertensive patients the conclusion was drawn 
that in normotensive control subjects the casual day-time 
blood pressure is a more varying quality than in hyperten-
sive patients. 
In Chapter V the first part of the above mentioned 
assessment of the relationship between the renin state of 
the patient and its significance in the choice of treatment 
of uncomplicated hypertension is described. In this study 
three antihypertensive maneuvers in the same group of 
normoreninemic hypertensive patients have been compared. 
The antihypertensive drugs used were the saluretic drug 
chlorthalidone, the anti-aldosterone agent spironolactone 
and the ß-adrenergic blocking drug propranolol. The first 
drug was included in this protocol because of its reported 
beneficial effect when used as basic maneuver in treating 
hypertensive patients. In order to study the role of the 
renin - angiotensin - aldosterone svstem in essential hyper-
tension more carefully the effects of the aldosterone 
antagonist spironolactone and the renin inhibitor proprano-
lol have been compared with the effect of saluretic treat-
ment with chlorthalidone. It should be mentioned, however, 
that other factors contribute to the blood pressure 
decrease obtained with these drugs. 
In addition to the effects of the drugs on blood 
pressure, plasma renin activity and plasma aldosterone, 
attention has been paid to changes in body weight, plasma 
electrolyte concentrations and glomerular filtration rate. 
Interestingly, with all three drugs, a comparable 
though not normalizing blood pressure decrease was effectu-
ated. Therefore, neither volume factors, nor relative hyper-
activity of the renin - aldosterone system nor ß-adrenergic 
hyperactivity can be considered to be prime movers in normo-
reninemic hypertension. Moreover, the maintenance of a 
supranormal blood pressure points to the presence of 
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mechanisms counteracting a decrease in blood pressure to 
normal levels. The high renin- and aldosterone levels found 
after long term chlorthalidone treatment were considered to 
be expressions of such counteracting mechanisms, as were 
the even higher renin levels measured after spironolactone. 
Finally, the weight increase observed during treatment with 
rather high doses of propranolol might represent volume 
retention as another mechanism counteracting the blood 
pressure lowering effect of this drug. 
The relevance of these considerations is illustrated 
by the greater effectiveness of the combination of ß-blockade 
and diuretics in the treatment of essential hypertension 
reported in the literature. 
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werkers van deze universiteit die ten behoeve van het ver-
zamelen van 'normale' waarden bereid waren aan niet altijd 
even plezierige proefopstellingen mee te werken. 
Respekt heb ik voor de patiënten die gedurende meer dan 
een jaar om de 14 dagen de polikliniek bezochten en zo een 
evaluatie van de behandeling met verschillende antihyperten-
sive mogelijk maakten. De gewaardeerde medewerking van 
collega Jan Festen heeft veel bijgedragen tot de voltooiing 
van dit onderzoek. 
Ook dank ik de verpleegkundigen van de polikliniek van 
de klinische afdelingen die steeds bereid zijn geweest mij 
bij mijn onderzoek behulpzaam te zijn. 
De heer W. 't Mannetje van het Instituut voor Wiskundi-
ge Dienstverlening (Hoofd Drs. J. van Eiteren) ben ik dank 
verschuldigd voor zijn adviezen en hulp wat betreft de sta-
tistische bewerking van de resultaten. Voor de medewerking 
aan het verzamelen van de benodigde literatuur dank ik het 
personeel van de Medische Bibliotheek (Hoofd Dr. E. de Graaff). 
Dank ook aan de heren van de Medische Illustratie (Hoofd J.J.M. 
de Bekker) en van de Medische Fotografie (Hoofd A.Th.A.I. 
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Tenslotte wil ik Lilian Hulsewé danken voor de goede 
samenwerking bij het uitwerken van het manuscript. 
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STELLINGEN 
1 
De betekenis van de minder dan normale stimuleerbaarheid van de plasma 
renine aktiviteit bij hypertensie is nog steeds omstreden, mede omdat aan 
de standaardizering van de meting van de plasma renine aktiviteit en aan 
de omstandigheden waaronder bloed voor deze meting wordt verzameld 
onvoldoende aandacht is besteed 
Dit proefschrift 
2 
Indien bij een patient een te lage plasma renine aktiviteit en een lage 
aldosteron secretiesnelheid gemeten worden, dient overmatig gebruik van 
drop uitgesloten te worden alvorens te denken aan een overproduktie van 
een ander - bekend of onbekend - mineralocorticoid 
3 
Gezien de recente literatuur gegevens betreffende het effekt van het (Des-
Asp') heptapeptide op de aldosteronproduktie door de zona glomerulosa in 
vitro, lijkt een vergelijkende studie van het effekt van angiotensine I I en 
van dit biologische derivaat van angiotensine I I op de secretiesnelheid van 
aldosteron bij de mens zinvol 
Ρ Fredlund, S Saltman and К J Catt 
J Clin Endocrinol Metab 40 746 - 749, 1975 
4 
In studies betreffende de relatie tussen de aanwezigheid van receptoren 
voor oestradiol in carcmomateus mammaweefsel en het optreden van klini­
sche remissies door een aantal endocriene maatregelen, dient vermeld te 
worden of de onderzochte patiënten pre- dan wel post-menopauzaal zijn 
5 
Het is onvoldoende bekend dat tijdens langdurige behandeling met 5-fluoro-
uracil een aanzienlijke stijging van het thyroxinegehalte in het plasma op-
treedt zonder enig klinisch kenmerk van hyperthyreoïdie. 
L. Beex, A. Ross, A. Smals and P. Kloppenborg 
Nog niet gepubliceerde waarnemingen. 
6 
Het ribbeboog - bekkenkam - syndroom kan onder andere bij bejaarde pa-
tiënten een simpele verklaring zijn voor in de buik of flank gelokaliseerde 
pijnklachten. 
J. Michels 
Ongepubliceerde waarnemingen. 
7 
Het is in het algemeen aan te raden om bij de statistische bewerking van 
klinische en biochemische gegevens betreffende patiënten non - parametri-
sche toetsen te gebruiken. 
8 
Een zorgvuldig opgezette prospectieve klinische studie lijkt noodzakelijk, 
teneinde de door Kaplan opgesomde argumenten tegen strenge zoutbeper-
king bij de preventie en de behandeling van preeclampsie te aanvaarden of 
te weerleggen. 
N. M. Kaplan, Clinical Hypertension 
Medcom press 1973, New York pp 313-314. 
9 
Voortschrijdend gebruik van de computer bij de opslag van gegevens uit 
wetenschappelijke literatuur zal leiden tot standaardizering en dientengevol-
ge tot verarming van taalgebruik, waardoor belangrijke nuances verloren 
kunnen gaan. 
10 
Bij het ontwerpen van personenwagens dient voor het aanbrengen van wet-
telijk verplichte of individueel gewenste vignetten ruimte op het koetswerk 
gecreëerd te worden, teneinde het rijden niet nog uitzicht-lozer te maken. 
26 juni 1975 
J. I. M. Drayer 


